Oncogenicity	O
of	O
human	B-cell_line
papillomavirus-	I-cell_line
or	I-cell_line
adenovirus-transformed	I-cell_line
cells	I-cell_line
correlates	O
with	O
resistance	O
to	O
lysis	O
by	O
natural	B-cell_type
killer	I-cell_type
cells	I-cell_type
.	O

The	O
reasons	O
for	O
the	O
dissimilar	O
oncogenicities	O
of	O
human	O
adenoviruses	O
and	O
human	O
papillomaviruses	O
(	O
HPV	O
)	O
in	O
humans	O
are	O
unknown	O
but	O
may	O
relate	O
to	O
differences	O
in	O
the	O
capacities	O
of	O
the	O
E1A	B-protein
and	O
E7	B-protein
proteins	I-protein
to	O
target	B-cell_type
cells	I-cell_type
for	O
rejection	O
by	O
the	O
host	B-cell_type
natural	I-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
cell	I-cell_type
response	O
.	O

As	O
one	O
test	O
of	O
this	O
hypothesis	O
,	O
we	O
compared	O
the	O
abilities	O
of	O
E1A	B-protein
-and	O
E7	B-protein
-expressing	O
human	B-cell_line
fibroblastic	I-cell_line
or	I-cell_line
keratinocyte-derived	I-cell_line
human	I-cell_line
cells	I-cell_line
to	O
be	O
selectively	O
killed	O
by	O
either	O
unstimulated	B-cell_type
or	O
interferon	B-cell_line
(	I-cell_line
IFN	I-cell_line
)	I-cell_line
-activated	I-cell_line
NK	I-cell_line
cells	I-cell_line
.	O

Cells	O
expressing	O
the	O
E1A	B-protein
oncoprotein	I-protein
were	O
selectively	O
killed	O
by	O
unstimulated	B-cell_line
NK	I-cell_line
cells	I-cell_line
,	O
while	O
the	O
same	O
parental	B-cell_type
cells	I-cell_type
but	O
expressing	O
the	O
HPV	O
type	O
16	O
(	O
HPV-16	O
)	O
or	O
HPV-18	O
E7	B-protein
oncoprotein	I-protein
were	O
resistant	O
to	O
NK	O
cell	O
lysis	O
.	O

The	O
ability	O
of	O
IFN-activated	B-cell_line
NK	I-cell_line
cells	I-cell_line
to	O
selectively	O
kill	O
virally	O
transformed	O
cells	O
depends	O
on	O
IFN	B-protein
's	O
ability	O
to	O
induce	O
resistance	O
to	O
NK	O
cell	O
lysis	O
in	O
normal	O
(	O
i.e.	O
,	O
non-viral	B-cell_line
oncogene-expressing	I-cell_line
)	O
but	O
not	O
virally	B-cell_line
transformed	I-cell_line
cells	I-cell_line
.	O

E1A	B-protein
blocked	O
IFN	B-protein
's	O
induction	O
of	O
cytolytic	O
resistance	O
,	O
resulting	O
in	O
the	O
selective	O
lysis	O
of	O
adenovirus-transformed	B-cell_line
cells	I-cell_line
by	O
IFN-activated	B-cell_line
NK	I-cell_line
cells	I-cell_line
.	O

The	O
extent	O
of	O
IFN	B-protein
-induced	O
NK	O
cell	O
killing	O
of	O
E1A-expressing	B-cell_line
cells	I-cell_line
was	O
proportional	O
to	O
the	O
level	O
of	O
E1A	B-protein
expression	O
and	O
correlated	O
with	O
the	O
ability	O
of	O
E1A	B-protein
to	O
block	O
IFN	B-protein
-stimulated	O
gene	O
expression	O
in	O
target	B-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
,	O
E7	B-protein
blocked	O
neither	O
IFN	B-protein
-stimulated	O
gene	O
expression	O
nor	O
IFN	B-protein
's	O
induction	O
of	O
cytolytic	O
resistance	O
,	O
thereby	O
precluding	O
the	O
selective	O
lysis	O
of	O
HPV-transformed	B-cell_line
cells	I-cell_line
by	O
IFN-activated	B-cell_line
NK	I-cell_line
cells	I-cell_line
.	O

In	O
conclusion	O
,	O
E1A	B-protein
expression	O
marks	O
cells	O
for	O
destruction	O
by	O
the	O
host	O
NK	B-cell_type
cell	I-cell_type
response	O
,	O
whereas	O
the	O
E7	B-protein
oncoprotein	I-protein
lacks	O
this	O
activity	O
.	O

JournaL	NULL
or	NULL
VirRoLOoGYy	NULL
,	NULL
Dec.	NULL
1995	NULL
,	NULL
p.	NULL
7639-7647	NULL
0022-538	NULL
X/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

69	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Oncogenicity	NULL
of	NULL
Human	NULL
Papillomavirus-	NULL
or	NULL
Adenovirus-Transformed	NULL
Cells	NULL
Correlates	NULL
with	NULL
Resistance	NULL
to	NULL
Lysis	NULL
by	NULL
Natural	NULL
Killer	NULL
Cells	NULL
JOHN	NULL
M.	NULL
ROUTES*	NULL
``	NULL
*	NULL
anp	NULL
SHARON	NULL
RYAN	NULL
!	NULL

Department	NULL
of	NULL
Medicine	NULL
,	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80206	NULL
,	NULL
``	NULL
and	NULL
Departments	NULL
of	NULL
Medicine®	NULL
and	NULL
Immunology	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Colorado	NULL
Health	NULL
Sciences	NULL
Center	NULL
,	NULL
Denver	NULL
,	NULL
Colorado	NULL
80262	NULL
Received	NULL
2	NULL
August	NULL
1995/Accepted	NULL
5	NULL
September	NULL
1995	NULL
The	NULL
reasons	NULL
for	NULL
the	NULL
dissimilar	NULL
oncogenicities	NULL
of	NULL
human	NULL
adenoviruses	NULL
and	NULL
human	NULL
papillomaviruses	NULL
(	NULL
HPV	NULL
)	NULL
in	NULL
humans	NULL
are	NULL
unknown	NULL
but	NULL
may	NULL
relate	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
capacities	NULL
of	NULL
the	NULL
ElA	NULL
and	NULL
E7	NULL
proteins	NULL
to	NULL
target	NULL
cells	NULL
for	NULL
rejection	NULL
by	NULL
the	NULL
host	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cell	NULL
response	NULL
.	NULL

As	NULL
one	NULL
test	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
abilities	NULL
of	NULL
E1A-	NULL
and	NULL
EZ7-expressing	NULL
human	NULL
fibroblastic	NULL
or	NULL
keratinocyte-derived	NULL
human	NULL
cells	NULL
to	NULL
be	NULL
selectively	NULL
killed	NULL
by	NULL
either	NULL
unstimulated	NULL
or	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
-activated	NULL
NK	NULL
cells	NULL
.	NULL

Cells	NULL
expressing	NULL
the	NULL
E1A	NULL
oncoprotein	NULL
were	NULL
selectively	NULL
killed	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
,	NULL
while	NULL
the	NULL
same	NULL
parental	NULL
cells	NULL
but	NULL
expressing	NULL
the	NULL
HPV	NULL
type	NULL
16	NULL
(	NULL
HPV-16	NULL
)	NULL
or	NULL
HPV-18	NULL
E7	NULL
oncoprotein	NULL
were	NULL
resistant	NULL
to	NULL
NK	NULL
cell	NULL
lysis	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
to	NULL
selectively	NULL
kill	NULL
virally	NULL
transformed	NULL
cells	NULL
depends	NULL
on	NULL
IFN	NULL
's	NULL
ability	NULL
to	NULL
induce	NULL
resistance	NULL
to	NULL
NK	NULL
cell	NULL
lysis	NULL
in	NULL
normal	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
non-viral	NULL
oncogene-expressing	NULL
)	NULL
but	NULL
not	NULL
virally	NULL
transformed	NULL
cells	NULL
.	NULL

E1A	NULL
blocked	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
selective	NULL
lysis	NULL
of	NULL
adenovirus-transformed	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
IFN-induced	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
E1A-expressing	NULL
cells	NULL
was	NULL
proportional	NULL
to	NULL
the	NULL
level	NULL
of	NULL
E1A	NULL
expression	NULL
and	NULL
correlated	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
ElA	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
in	NULL
target	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
E7	NULL
blocked	NULL
neither	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
nor	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
,	NULL
thereby	NULL
precluding	NULL
the	NULL
selective	NULL
lysis	NULL
of	NULL
HPV-transformed	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
E1A	NULL
expression	NULL
marks	NULL
cells	NULL
for	NULL
destruction	NULL
by	NULL
the	NULL
host	NULL
NK	NULL
cell	NULL
response	NULL
,	NULL
whereas	NULL
the	NULL
E7	NULL
oncoprotein	NULL
lacks	NULL
this	NULL
activity	NULL
.	NULL

Human	NULL
papillomaviruses	NULL
(	NULL
HPV	NULL
)	NULL
and	NULL
adenoviruses	NULL
(	NULL
Ad	NULL
)	NULL
are	NULL
common	NULL
human	NULL
pathogens	NULL
with	NULL
a	NULL
propensity	NULL
to	NULL
cause	NULL
persistent	NULL
infections	NULL
.	NULL

For	NULL
example	NULL
,	NULL
at	NULL
least	NULL
95	NULL
%	NULL
of	NULL
adults	NULL
are	NULL
sero-positive	NULL
to	NULL
one	NULL
of	NULL
the	NULL
group	NULL
C	NULL
Ad	NULL
(	NULL
65	NULL
)	NULL
,	NULL
and	NULL
in	NULL
the	NULL
United	NULL
States	NULL
alone	NULL
,	NULL
over	NULL
12	NULL
million	NULL
sexually	NULL
active	NULL
adults	NULL
are	NULL
infected	NULL
with	NULL
genital	NULL
tract	NULL
HPV	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
evolutionarily	NULL
distinct	NULL
,	NULL
Ad	NULL
and	NULL
HPV	NULL
share	NULL
one	NULL
important	NULL
feature	NULL
:	NULL
both	NULL
viruses	NULL
transform	NULL
mammalian	NULL
cells	NULL
(	NULL
including	NULL
human	NULL
cells	NULL
)	NULL
through	NULL
the	NULL
expression	NULL
of	NULL
viral	NULL
oncoproteins	NULL
(	NULL
HPV	NULL
E7	NULL
and	NULL
E6	NULL
;	NULL
Ad	NULL
E1A	NULL
and	NULL
E1B	NULL
)	NULL
that	NULL
exhibit	NULL
strikingly	NULL
similar	NULL
biological	NULL
activities	NULL
(	NULL
18	NULL
,	NULL
19	NULL
,	NULL
49	NULL
,	NULL
60	NULL
,	NULL
70	NULL
,	NULL
71	NULL
,	NULL
75	NULL
,	NULL
76	NULL
)	NULL
.	NULL

In	NULL
HPV-induced	NULL
human	NULL
malignancies	NULL
(	NULL
2	NULL
,	NULL
61	NULL
,	NULL
64	NULL
)	NULL
or	NULL
Ad-transformed	NULL
cells	NULL
(	NULL
29	NULL
,	NULL
34	NULL
)	NULL
,	NULL
there	NULL
is	NULL
viral	NULL
integration	NULL
into	NULL
the	NULL
host	NULL
genome	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
two	NULL
viral	NULL
genes	NULL
(	NULL
HPV	NULL
E6	NULL
and	NULL
E7	NULL
;	NULL
Ad	NULL
E1A	NULL
and	NULL
E1B	NULL
)	NULL
is	NULL
consistently	NULL
found	NULL
.	NULL

Although	NULL
expression	NULL
of	NULL
E6	NULL
and	NULL
E7	NULL
or	NULL
E1A	NULL
and	NULL
E1B	NULL
is	NULL
required	NULL
for	NULL
the	NULL
efficient	NULL
transformation	NULL
of	NULL
primary	NULL
cells	NULL
,	NULL
either	NULL
the	NULL
HPV	NULL
E7	NULL
gene	NULL
(	NULL
32	NULL
)	NULL
or	NULL
Ad	NULL
E1A	NULL
gene	NULL
(	NULL
29	NULL
,	NULL
34	NULL
)	NULL
alone	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
immortalization	NULL
of	NULL
primary	NULL
cells	NULL
and	NULL
therefore	NULL
represents	NULL
the	NULL
major	NULL
transforming	NULL
gene	NULL
of	NULL
HPV	NULL
or	NULL
Ad	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
E1A	NULL
oncoprotein	NULL
exhibits	NULL
both	NULL
functional	NULL
and	NULL
amino	NULL
acid	NULL
homology	NULL
with	NULL
the	NULL
E7	NULL
oncoprotein	NULL
.	NULL

Amino	NULL
acids	NULL
encoded	NULL
within	NULL
the	NULL
homologous	NULL
regions	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
(	NULL
conserved	NULL
region	NULL
1	NULL
[	NULL
CR1	NULL
]	NULL
and	NULL
CR2	NULL
)	NULL
serve	NULL
as	NULL
sites	NULL
of	NULL
high-affinity	NULL
binding	NULL
to	NULL
specific	NULL
cellular	NULL
proteins	NULL
(	NULL
p105	NULL
or	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
;	NULL
p107	NULL
,	NULL
p130	NULL
,	NULL
and	NULL
cyclin	NULL
A	NULL
)	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
,	NULL
thereby	NULL
transduc-ing	NULL
the	NULL
many	NULL
biological	NULL
activities	NULL
shared	NULL
by	NULL
these	NULL
viral	NULL
oncoproteins	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
transactivation	NULL
of	NULL
the	NULL
E2	NULL
promoter	NULL
through	NULL
the	NULL
generation	NULL
of	NULL
free	NULL
E2F	NULL
,	NULL
cooperation	NULL
with	NULL
an	NULL
activated	NULL
ras	NULL
on	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Medicine	NULL
,	NULL
1400	NULL
Jackson	NULL
St.	NULL
,	NULL
Denver	NULL
,	NULL
CO	NULL
80206	NULL
.	NULL

7639	NULL
cogene	NULL
to	NULL
transform	NULL
baby	NULL
rat	NULL
kidney	NULL
cells	NULL
,	NULL
blocking	NULL
transforming	NULL
growth	NULL
factor	NULL
type	NULL
B-induced	NULL
transrepression	NULL
of	NULL
the	NULL
c-myc	NULL
promoter	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
cellular	NULL
apoptosis	NULL
)	NULL
(	NULL
35	NULL
,	NULL
45	NULL
,	NULL
48-50	NULL
,	NULL
52	NULL
)	NULL
.	NULL
)	NULL

A1though	NULL
genetically	NULL
unrelated	NULL
,	NULL
E6	NULL
oncoproteins	NULL
derived	NULL
from	NULL
the	NULL
oncogenic	NULL
HPV	NULL
and	NULL
Ad	NULL
E1B	NULL
p55	NULL
oncoproteins	NULL
both	NULL
inhibit	NULL
the	NULL
biological	NULL
activities	NULL
of	NULL
the	NULL
tumor	NULL
suppressor	NULL
gene	NULL
p53	NULL
.	NULL

The	NULL
HPV	NULL
E6	NULL
oncoprotein	NULL
complexes	NULL
with	NULL
the	NULL
cellular	NULL
protein	NULL
p53	NULL
,	NULL
leading	NULL
to	NULL
its	NULL
rapid	NULL
degradation	NULL
(	NULL
60	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
E1B	NULL
p55	NULL
binds	NULL
to	NULL
p53	NULL
,	NULL
sequestering	NULL
p53	NULL
from	NULL
the	NULL
nucleus	NULL
and	NULL
blocking	NULL
p53	NULL
transactivation	NULL
function	NULL
(	NULL
75	NULL
,	NULL
76	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
their	NULL
ubiquity	NULL
and	NULL
competence	NULL
to	NULL
transform	NULL
human	NULL
cells	NULL
,	NULL
Ad	NULL
appear	NULL
to	NULL
be	NULL
nononcogenic	NULL
in	NULL
humans	NULL
(	NULL
30	NULL
)	NULL
,	NULL
whereas	NULL
HPV	NULL
have	NULL
been	NULL
linked	NULL
to	NULL
as	NULL
many	NULL
as	NULL
90	NULL
%	NULL
of	NULL
cervical	NULL
carcinomas	NULL
(	NULL
77	NULL
)	NULL
.	NULL

The	NULL
reasons	NULL
for	NULL
the	NULL
dissimilar	NULL
oncogenicities	NULL
of	NULL
Ad	NULL
and	NULL
HPV	NULL
in	NULL
humans	NULL
are	NULL
unknown	NULL
,	NULL
but	NULL
an	NULL
analogous	NULL
situation	NULL
exists	NULL
with	NULL
Ad-induced	NULL
tumors	NULL
in	NULL
rodents	NULL
.	NULL

Although	NULL
group	NULL
A	NULL
(	NULL
Ad	NULL
serotype	NULL
12	NULL
[	NULL
Ad12	NULL
]	NULL
)	NULL
and	NULL
group	NULL
C	NULL
(	NULL
Ad2	NULL
and	NULL
Ad5	NULL
)	NULL
Ad	NULL
are	NULL
equally	NULL
immunogenic	NULL
and	NULL
transform	NULL
rodent	NULL
cells	NULL
with	NULL
equal	NULL
efficiency	NULL
(	NULL
25	NULL
,	NULL
39	NULL
)	NULL
,	NULL
only	NULL
group	NULL
A	NULL
Ad	NULL
are	NULL
tumorigenic	NULL
in	NULL
immunocompetent	NULL
rodents	NULL
.	NULL

In	NULL
studies	NULL
comparing	NULL
group	NULL
A	NULL
and	NULL
group	NULL
C	NULL
Ad	NULL
,	NULL
the	NULL
tumorigenicity	NULL
of	NULL
the	NULL
different	NULL
Ad	NULL
groups	NULL
in	NULL
rodents	NULL
appears	NULL
to	NULL
be	NULL
related	NULL
to	NULL
the	NULL
susceptibility	NULL
(	NULL
Ad2	NULL
and	NULL
Ad5	NULL
)	NULL
or	NULL
resistance	NULL
(	NULL
Ad12	NULL
)	NULL
of	NULL
Ad-infected	NULL
or	NULL
Ad-transformed	NULL
cells	NULL
to	NULL
elimination	NULL
by	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
,	NULL
a	NULL
process	NULL
regulated	NULL
by	NULL
differences	NULL
between	NULL
Ad12	NULL
E1A	NULL
and	NULL
Ad2	NULL
and	NULL
AdS	NULL
E1A	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
40	NULL
,	NULL
59	NULL
,	NULL
62	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
studies	NULL
in	NULL
rodents	NULL
,	NULL
we	NULL
speculated	NULL
that	NULL
NK	NULL
cells	NULL
would	NULL
also	NULL
be	NULL
an	NULL
important	NULL
immunologic	NULL
defense	NULL
in	NULL
limiting	NULL
adenoviral	NULL
infections	NULL
and	NULL
in	NULL
preventing	NULL
Ad-induced	NULL
malignancy	NULL
in	NULL
humans	NULL
.	NULL

Studies	NULL
performed	NULL
to	NULL
date	NULL
using	NULL
human	NULL
cells	NULL
are	NULL
consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
.	NULL

Non-cytokine-activated	NULL
NK	NULL
cells	NULL
selectively	NULL
kill	NULL
Ad-transformed	NULL
cells	NULL
but	NULL
not	NULL
7640	NULL
ROUTES	NULL
AND	NULL
RYAN	NULL
Ad-infected	NULL
cells	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
,	NULL
whereas	NULL
interferon	NULL
(	NULL
IFN	NULL
)	NULL
induces	NULL
the	NULL
discriminate	NULL
killing	NULL
of	NULL
both	NULL
infected	NULL
and	NULL
transformed	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

In	NULL
both	NULL
of	NULL
these	NULL
instances	NULL
,	NULL
the	NULL
selective	NULL
NK	NULL
cell	NULL
lysis	NULL
of	NULL
either	NULL
Ad-infected	NULL
or	NULL
Ad-transformed	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
E1A	NULL
gene	NULL
products	NULL
.	NULL

The	NULL
purpose	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
compare	NULL
the	NULL
abilities	NULL
of	NULL
the	NULL
E1A	NULL
and	NULL
E7	NULL
oncoproteins	NULL
to	NULL
induce	NULL
the	NULL
discriminate	NULL
lysis	NULL
of	NULL
Ad-	NULL
or	NULL
HPV	NULL
-transformed	NULL
human	NULL
cells	NULL
by	NULL
either	NULL
unstimulated	NULL
or	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

Whereas	NULL
the	NULL
stable	NULL
expression	NULL
of	NULL
AdS	NULL
E1A	NULL
oncoprotein	NULL
in	NULL
cytolytic	NULL
resistant	NULL
fibroblastic	NULL
or	NULL
keratinocyte-derived	NULL
human	NULL
cells	NULL
induced	NULL
an	NULL
increased	NULL
susceptibility	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
(	NULL
non-cytokine-activated	NULL
)	NULL
NK	NULL
cells	NULL
,	NULL
the	NULL
HPV	NULL
type	NULL
16	NULL
(	NULL
HPV-16	NULL
)	NULL
or	NULL
HPV-18	NULL
E7	NULL
oncoprotein	NULL
lacked	NULL
this	NULL
activity	NULL
.	NULL

IFN	NULL
(	NULL
-	NULL
«	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-y	NULL
)	NULL
increase	NULL
the	NULL
cytolytic	NULL
capacity	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
selectivity	NULL
of	NULL
killing	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
depends	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
on	NULL
to	NULL
NK	NULL
cell	NULL
killing	NULL
on	NULL
normal	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
non-viral	NULL
oncogene-expressing	NULL
)	NULL
but	NULL
not	NULL
virally	NULL
transformed	NULL
cells	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Experiments	NULL
reported	NULL
here	NULL
showed	NULL
that	NULL
IFN-y	NULL
treatment	NULL
reduced	NULL
the	NULL
IFN-activated	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
both	NULL
E7-expressing	NULL
and	NULL
non-E7-expressing	NULL
cells	NULL
to	NULL
equivalent	NULL
degrees	NULL
,	NULL
thereby	NULL
precluding	NULL
the	NULL
selective	NULL
lysis	NULL
of	NULL
HPV-transformed	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
E1A	NULL
expression	NULL
blocked	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
,	NULL
thereby	NULL
permitting	NULL
the	NULL
selective	NULL
killing	NULL
of	NULL
E1A-expressing	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

IFN	NULL
's	NULL
capacity	NULL
to	NULL
induce	NULL
cytolytic	NULL
resistance	NULL
is	NULL
likely	NULL
secondary	NULL
to	NULL
its	NULL
capacity	NULL
to	NULL
transcriptionally	NULL
activate	NULL
selected	NULL
cellular	NULL
genes	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
IFN-stimulated	NULL
genes	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
capacities	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
to	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
may	NULL
reflect	NULL
dissimilarities	NULL
in	NULL
their	NULL
abilities	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
found	NULL
that	NULL
E1A	NULL
but	NULL
not	NULL
E7	NULL
expression	NULL
blocked	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
to	NULL
increase	NULL
IFN	NULL
regulatory	NULL
factor	NULL
1	NULL
(	NULL
IRF-1	NULL
)	NULL
transcription	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
results	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
the	NULL
NK	NULL
cell	NULL
response	NULL
would	NULL
form	NULL
an	NULL
effective	NULL
immunologic	NULL
barrier	NULL
against	NULL
the	NULL
escape	NULL
and	NULL
neoplastic	NULL
progression	NULL
of	NULL
Ad-	NULL
but	NULL
not	NULL
HPV-transformed	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
differences	NULL
in	NULL
the	NULL
capacities	NULL
of	NULL
the	NULL
E1A	NULL
and	NULL
E7	NULL
proteins	NULL
to	NULL
target	NULL
cells	NULL
for	NULL
destruction	NULL
by	NULL
the	NULL
host	NULL
NK	NULL
cell	NULL
response	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
dissimilar	NULL
oncogenicities	NULL
of	NULL
Ad	NULL
and	NULL
HPV	NULL
in	NULL
humans	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

CaSki	NULL
,	NULL
SiHa	NULL
,	NULL
HeLa	NULL
,	NULL
and	NULL
HeLa	NULL
$	NULL
3	NULL
are	NULL
HPV-16	NULL
(	NULL
CaSki	NULL
and	NULL
SiHa	NULL
)	NULL
-	NULL
and	NULL
HPV-18	NULL
(	NULL
HeLa	NULL
and	NULL
HeLa	NULL
S3	NULL
)	NULL
-transformed	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
lines	NULL
(	NULL
74	NULL
)	NULL
.	NULL

M18	NULL
is	NULL
an	NULL
Ad5	NULL
E1A-transfected	NULL
HeLa	NULL
cell	NULL
line	NULL
provided	NULL
by	NULL
S.	NULL
Frisch	NULL
(	NULL
La	NULL
Jolla	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

A431	NULL
is	NULL
a	NULL
non-HPV-expressing	NULL
vulvar	NULL
epidermoid	NULL
carcinoma	NULL
cell	NULL
line	NULL
(	NULL
74	NULL
)	NULL
.	NULL

HeLa	NULL
c-env	NULL
is	NULL
a	NULL
HeLa	NULL
cell	NULL
line	NULL
which	NULL
stably	NULL
expresses	NULL
the	NULL
neomycin	NULL
selection	NULL
gene	NULL
and	NULL
envelope	NULL
gene	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
was	NULL
provided	NULL
by	NULL
Miguel	NULL
Gama	NULL
Sosa	NULL
and	NULL
Ruth	NULL
Reprecht	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

(	NULL
26	NULL
)	NULL
.	NULL

HFK-1321	NULL
is	NULL
a	NULL
human	NULL
epidermal	NULL
keratinocyte	NULL
cell	NULL
line	NULL
transformed	NULL
by	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HPV-16	NULL
F6	NULL
and	NULL
E7	NULL
genes	NULL
expressed	NULL
from	NULL
a	NULL
human	NULL
B-actin	NULL
promoter	NULL
.	NULL

18NCO	NULL
is	NULL
a	NULL
human	NULL
epidermal	NULL
keratinocyte	NULL
cell	NULL
line	NULL
transformed	NULL
by	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
full	NULL
HPV-18	NULL
genome	NULL
linearized	NULL
at	NULL
a	NULL
unique	NULL
Neo	NULL
!	NULL

site	NULL
.	NULL

Both	NULL
HFK-1321	NULL
and	NULL
18NCO	NULL
were	NULL
provided	NULL
by	NULL
Karl	NULL
Miinger	NULL
(	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

(	NULL
44	NULL
)	NULL
.	NULL

IC4	NULL
is	NULL
a	NULL
HeLa	NULL
$	NULL
3	NULL
cell	NULL
line	NULL
transfected	NULL
with	NULL
the	NULL
Ad2	NULL
E1A	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
murine	NULL
mammary	NULL
tumor	NULL
virus	NULL
promoter	NULL
and	NULL
was	NULL
provided	NULL
by	NULL
A.	NULL
Berk	NULL
(	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Los	NULL
Angeles	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IC4-D10	NULL
is	NULL
a	NULL
subclone	NULL
of	NULL
IC4	NULL
obtained	NULL
by	NULL
limiting	NULL
dilution	NULL
(	NULL
58	NULL
)	NULL
.	NULL

WI-38	NULL
is	NULL
a	NULL
human	NULL
embryonal	NULL
diploid	NULL
fibroblast	NULL
cell	NULL
line	NULL
.	NULL

A431	NULL
,	NULL
WI-38	NULL
,	NULL
HeLa	NULL
$	NULL
3	NULL
,	NULL
HeLa	NULL
,	NULL
SiHa	NULL
,	NULL
and	NULL
CaSki	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

H4	NULL
is	NULL
a	NULL
subclone	NULL
of	NULL
the	NULL
HT1080	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
.	NULL

P2AHT2A	NULL
is	NULL
an	NULL
Ad5	NULL
E1A-transfected	NULL
H4	NULL
cell	NULL
line	NULL
(	NULL
23	NULL
)	NULL
.	NULL

H4-E7	NULL
clone	NULL
1	NULL
(	NULL
CL1	NULL
)	NULL
and	NULL
CL2	NULL
are	NULL
H4	NULL
cells	NULL
which	NULL
stably	NULL
express	NULL
the	NULL
HPV-16	NULL
E7	NULL
gene	NULL
following	NULL
transfection	NULL
with	NULL
pLSXN16E7	NULL
.	NULL

WI-38	NULL
E7	NULL
CL2	NULL
and	NULL
CL4	NULL
are	NULL
WI-38	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
HPV-16	NULL
E7	NULL
and	NULL
E6	NULL
genes	NULL
following	NULL
transfection	NULL
with	NULL
plasmid	NULL
pLSXN16E7/16F6	NULL
.	NULL

pLSXN16E7	NULL
and	NULL
pLSXN16E7/16E6	NULL
contain	NULL
the	NULL
HPV-16	NULL
E7	NULL
and	NULL
HPV-16	NULL
E7	NULL
and	NULL
E6	NULL
genes	NULL
,	NULL
respectively	NULL
,	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
and	NULL
the	NULL
neomycin	NULL
selection	NULL
gene	NULL
(	NULL
32	NULL
)	NULL
.	NULL

H4-E7	NULL
CL1	NULL
and	NULL
J.	NULL
ViroL	NULL
.	NULL

CL2	NULL
and	NULL
WI-38	NULL
E7	NULL
CL2	NULL
and	NULL
CL4	NULL
were	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
from	NULL
G418-resistant	NULL
colonies	NULL
selected	NULL
from	NULL
separate	NULL
plates	NULL
.	NULL

pLSXN16E7/16E6	NULL
and	NULL
pLSXN16E7	NULL
were	NULL
provided	NULL
by	NULL
D.	NULL
Galloway	NULL
(	NULL
Fred	NULL
Hutchison	NULL
Cancer	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
Wash.	NULL
)	NULL
.	NULL

HFK-1321	NULL
and	NULL
18	NULL
NCO	NULL
were	NULL
maintained	NULL
in	NULL
keratinocyte	NULL
growth	NULL
medium	NULL
(	NULL
Clo-netics	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

SiHa	NULL
and	NULL
CaSki	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640-10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
plus	NULL
antibiotics	NULL
.	NULL

A431	NULL
,	NULL
H4	NULL
,	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
,	NULL
P2AHT2A	NULL
,	NULL
Hela	NULL
,	NULL
Hela	NULL
$	NULL
3	NULL
,	NULL
Hela	NULL
c-env	NULL
,	NULL
and	NULL
IC4-D10	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
,	NULL
15	NULL
mM	NULL
glu-cose	NULL
,	NULL
and	NULL
5	NULL
%	NULL
FCS	NULL
.	NULL

WI-38	NULL
and	NULL
WI-38	NULL
E7	NULL
CL2	NULL
to	NULL
CL4	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
,	NULL
15	NULL
mM	NULL
glu-cose	NULL
,	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

IC4-D10	NULL
was	NULL
incubated	NULL
with	NULL
dexamethasone	NULL
added	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
to	NULL
standard	NULL
culture	NULL
medium	NULL
for	NULL
5	NULL
days	NULL
to	NULL
induce	NULL
maximal	NULL
E1A	NULL
expression	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
periodically	NULL
tested	NULL
for	NULL
mycoplasma	NULL
contamination	NULL
by	NULL
the	NULL
Mycotet	NULL
assay	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laboratories	NULL
,	NULL
Bethesda	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

and	NULL
were	NULL
negative	NULL
.	NULL

NK	NULL
cell	NULL
cytolysis	NULL
assays	NULL
.	NULL

Cytolysis	NULL
assays	NULL
using	NULL
non-cytokine-activated	NULL
NK	NULL
cells	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Piscataway	NULL
,	NULL
N.J.	NULL
)	NULL
-separated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
served	NULL
as	NULL
the	NULL
source	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

Target	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
**Cr	NULL
(	NULL
100	NULL
mCi/ml	NULL
for	NULL
1	NULL
h	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
GBq	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
and	NULL
target	NULL
cells	NULL
(	NULL
104	NULL
)	NULL
were	NULL
cosedimented	NULL
at	NULL
different	NULL
effector-to-target	NULL
cell	NULL
ratios	NULL
in	NULL
flat-bottom	NULL
microtiter	NULL
plates	NULL
by	NULL
centrif-ugation	NULL
at	NULL
500	NULL
x	NULL
g	NULL
for	NULL
3	NULL
min	NULL
,	NULL
and	NULL
after	NULL
a	NULL
4-h	NULL
incubation	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
half	NULL
of	NULL
the	NULL
supernatant	NULL
from	NULL
cach	NULL
well	NULL
was	NULL
harvested	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
gamma	NULL
counter	NULL
.	NULL

NK	NULL
cell	NULL
killing	NULL
was	NULL
determined	NULL
by	NULL
calculating	NULL
the	NULL
percentage	NULL
of	NULL
NK	NULL
cell-induced	NULL
release	NULL
of	NULL
radiolabel	NULL
from	NULL
target	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
represent	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
(	NULL
SEM	NULL
)	NULL
of	NULL
at	NULL
least	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
mean	NULL
percentage	NULL
spontaneous	NULL
release	NULL
from	NULL
all	NULL
target	NULL
cells	NULL
,	NULL
including	NULL
those	NULL
infected	NULL
with	NULL
Ad	NULL
,	NULL
was	NULL
less	NULL
than	NULL
15	NULL
%	NULL
.	NULL

For	NULL
cytolysis	NULL
assays	NULL
using	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
,	NULL
Ficoll-Paque-separated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
10,000	NULL
U	NULL
of	NULL
recombinant	NULL
IFN-	NULL
«	NULL
2	NULL
(	NULL
Schering	NULL
Corp.	NULL
,	NULL
Kenilworth	NULL
,	NULL
N.J.	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
this	NULL
concentration	NULL
of	NULL
IFN-	NULL
«	NULL
2	NULL
results	NULL
in	NULL
optimal	NULL
activation	NULL
of	NULL
human	NULL
NK	NULL
cells	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
from	NULL
this	NULL
laboratory	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
by	NULL
other	NULL
authors	NULL
(	NULL
21	NULL
,	NULL
68	NULL
)	NULL
demonstrate	NULL
that	NULL
the	NULL
cytolytic	NULL
activity	NULL
in	NULL
this	NULL
population	NULL
of	NULL
cells	NULL
as	NULL
measured	NULL
in	NULL
4-h	NULL
cytolysis	NULL
assays	NULL
is	NULL
mediated	NULL
by	NULL
CD-16	NULL
positive	NULL
NK	NULL
cells	NULL
.	NULL

Target	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10,000	NULL
U	NULL
of	NULL
recombinant	NULL
IFN-y	NULL
(	NULL
Genentech	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
24	NULL
h.	NULL
Prior	NULL
studies	NULL
from	NULL
this	NULL
laboratory	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
concentration	NULL
of	NULL
IFN-y	NULL
induces	NULL
maximal	NULL
cytolytic	NULL
resistance	NULL
(	NULL
53	NULL
)	NULL
.	NULL

With	NULL
the	NULL
exception	NULL
of	NULL
IFN	NULL
treatment	NULL
,	NULL
these	NULL
cytolysis	NULL
assays	NULL
were	NULL
then	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
prior	NULL
paragraph	NULL
.	NULL

In	NULL
cytolysis	NULL
assays	NULL
which	NULL
used	NULL
cells	NULL
incubated	NULL
with	NULL
dexamethasone	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
extensively	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
prior	NULL
to	NULL
the	NULL
labeling	NULL
step	NULL
.	NULL

No	NULL
exogenous	NULL
dexamethasone	NULL
was	NULL
present	NULL
during	NULL
the	NULL
cytolysis	NULL
assay	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
represent	NULL
the	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
at	NULL
least	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
mean	NULL
percent	NULL
spontancous	NULL
release	NULL
from	NULL
all	NULL
target	NULL
cells	NULL
was	NULL
similar	NULL
and	NULL
always	NULL
less	NULL
than	NULL
15	NULL
%	NULL
.	NULL

Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
analysis	NULL
of	NULL
viral	NULL
proteins	NULL
.	NULL

For	NULL
quantitation	NULL
of	NULL
ElA	NULL
proteins	NULL
,	NULL
60-mm-diameter	NULL
plates	NULL
of	NULL
IC4-D10	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
log	NULL
dilu-tions	NULL
of	NULL
dexamethasone	NULL
(	NULL
1075	NULL
,	NULL
107	NULL
``	NULL
,	NULL
10~	NULL
``	NULL
,	NULL
and	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
5	NULL
days	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
16	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
10,000	NULL
U/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
dexamethasone	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
radioimmunoprecipitation	NULL
assay	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
[	NULL
SDS	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
)	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
of	NULL
radicimmunopre-cipitation	NULL
assay	NULL
supernatants	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
bicinchoninic	NULL
acid	NULL
protein	NULL
assay	NULL
(	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
Ill.	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
all	NULL
cell	NULL
lysates	NULL
were	NULL
separated	NULL
on	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Each	NULL
membrane	NULL
was	NULL
blocked	NULL
in	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
solution	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
anti-E1A	NULL
monoclonal	NULL
antibody	NULL
M73	NULL
(	NULL
33	NULL
)	NULL
,	NULL
supplied	NULL
by	NULL
E.	NULL
Harlow	NULL
(	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Charleston	NULL
)	NULL
,	NULL
for	NULL
1	NULL
h.	NULL
Following	NULL
several	NULL
washes	NULL
with	NULL
PBST	NULL
(	NULL
PBS	NULL
with	NULL
0.05	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
rabbit	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Cappel	NULL
,	NULL
Durham	NULL
,	NULL
N.C.	NULL
)	NULL
,	NULL
washed	NULL
extensively	NULL
with	NULL
PBST	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
***I-labeled	NULL
protein	NULL
A	NULL
(	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Following	NULL
several	NULL
washes	NULL
with	NULL
PBST	NULL
,	NULL
the	NULL
bands	NULL
were	NULL
visualized	NULL
by	NULL
fluorography	NULL
.	NULL

Quantitation	NULL
of	NULL
E7	NULL
proteins	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
procedure	NULL
used	NULL
for	NULL
E1A	NULL
,	NULL
with	NULL
the	NULL
following	NULL
exceptions	NULL
:	NULL
the	NULL
cell	NULL
lysis	NULL
buffer	NULL
contained	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
aprotinin	NULL
,	NULL
and	NULL
1	NULL
M	NULL
phenyImethylsulfonyl	NULL
fluoride	NULL
;	NULL
following	NULL
incubation	NULL
with	NULL
the	NULL
anti-E7	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Triton	NULL
Diagnostics	NULL
,	NULL
Alameda	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
the	NULL
E7	NULL
protein	NULL
was	NULL
visualized	NULL
as	NULL
instructed	NULL
by	NULL
the	NULL
manufacturer	NULL
,	NULL
using	NULL
a	NULL
Renaissance	NULL
chemi-luminescence	NULL
kit	NULL
(	NULL
DuPont-NEN	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Northern	NULL
(	NULL
RNA	NULL
)	NULL
analysis	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
to	NULL
10	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
5,000	NULL
U	NULL
of	NULL
recombinant	NULL
IFN-y	NULL
(	NULL
Genentech	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
4	NULL
h.	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
NP-40	NULL
lysis	NULL
method	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
67	NULL
)	NULL
,	NULL
with	NULL
only	NULL
slight	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
mg	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
formaldehyde	NULL
,	NULL
photographed	NULL
to	NULL
assess	NULL
RNA	NULL
quantity	NULL
and	NULL
quality	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
MSI	NULL
hybridization	NULL
transfer	NULL
membrane	NULL
)	NULL
by	NULL
capillary	NULL
blotting	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
baked	NULL
at	NULL
80°C	NULL
for	NULL
2	NULL
h	NULL
and	NULL
hybridized	NULL
to	NULL
a	NULL
*°P-labeled	NULL
cDNA	NULL
probe	NULL
at	NULL
42°C	NULL
in	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
solution-50	NULL
%	NULL
formamide-5	NULL
x	NULL
SSC	NULL
(	NULL
1	NULL
%	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
-0.05	NULL
mg	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
per	NULL
ml	NULL
,	NULL
-50	NULL
mM	NULL
NaPO	NULL
,	NULL
-1.0	NULL
%	NULL
SDS	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
.	NULL

After	NULL
overnight	NULL
hybridization	NULL
,	NULL
the	NULL
nylon	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
1	NULL
40	NULL
so	NULL
120	NULL
___	NULL
140	NULL
E1A	NULL
|	NULL
|	NULL
crt	NULL
|	NULL
CR2	NULL
1	NULL
iz	NULL
is	NULL
|__	NULL
37	NULL
mmm	NULL
98	NULL
er	NULL
[	NULL
omi	NULL
|	NULL
one	NULL
|	NULL
___	NULL
]	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Areas	NULL
of	NULL
conserved	NULL
region	NULL
homology	NULL
between	NULL
E1A	NULL
and	NULL
HPV	NULL
E7	NULL
.	NULL

The	NULL
first	NULL
140	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
E1A	NULL
oncoprotein	NULL
are	NULL
shown	NULL
,	NULL
and	NULL
the	NULL
locations	NULL
(	NULL
amino	NULL
acid	NULL
numbers	NULL
)	NULL
of	NULL
CR1	NULL
and	NULL
CR2	NULL
are	NULL
indicated	NULL
.	NULL

Areas	NULL
of	NULL
amino	NULL
acid	NULL
homology	NULL
between	NULL
E1A	NULL
and	NULL
E7	NULL
are	NULL
indicated	NULL
by	NULL
black	NULL
bars	NULL
with	NULL
corresponding	NULL
amino	NULL
acid	NULL
numbers	NULL
.	NULL

membrane	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
3X	NULL
SSC-1	NULL
%	NULL
SDS	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
a	NULL
final	NULL
wash	NULL
in	NULL
0.1	NULL
%	NULL
SSC-0.1	NULL
%	NULL
phosphate-1	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
.	NULL

Autoradiography	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
-70°C	NULL
,	NULL
using	NULL
an	NULL
intensifier	NULL
screen	NULL
.	NULL

The	NULL
human	NULL
cDNA	NULL
probe	NULL
for	NULL
the	NULL
IFN-y-regulated	NULL
gene	NULL
,	NULL
encoding	NULL
IRF-1	NULL
,	NULL
was	NULL
provided	NULL
by	NULL
A.	NULL
Deisseroth	NULL
(	NULL
M.	NULL
D.	NULL
Anderson	NULL
Cancer	NULL
Center	NULL
,	NULL
Houston	NULL
,	NULL
Tex	NULL
.	NULL
)	NULL

.	NULL

The	NULL
human	NULL
cDNA	NULL
probe	NULL
for	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
J.	NULL
Domenico	NULL
and	NULL
E.	NULL
Gelfand	NULL
(	NULL
National	NULL
Jewish	NULL
Center	NULL
for	NULL
Immunology	NULL
and	NULL
Respiratory	NULL
Medicine	NULL
,	NULL
Denver	NULL
,	NULL
Colo.	NULL
)	NULL
.	NULL

Both	NULL
cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
primer	NULL
method	NULL
.	NULL

RESULTS	NULL
HPV	NULL
E7	NULL
expression	NULL
does	NULL
not	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
in	NULL
keratinocyte-derived	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
discriminate	NULL
killing	NULL
of	NULL
Ad-infected	NULL
or	NULL
Ad-transformed	NULL
human	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
IFN	NULL
's	NULL
dissimilar	NULL
effects	NULL
on	NULL
normal	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
non-viral	NULL
oncogene-expressing	NULL
)	NULL
cells	NULL
in	NULL
comparison	NULL
with	NULL
Ad-infected	NULL
or	NULL
Ad-transformed	NULL
cells	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

On	NULL
normal	NULL
cells	NULL
,	NULL
IFN	NULL
induces	NULL
an	NULL
enhanced	NULL
state	NULL
of	NULL
cytolytic	NULL
resistance	NULL
to	NULL
killing	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
ElA	NULL
expression	NULL
blocks	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
,	NULL
thereby	NULL
focusing	NULL
NK	NULL
lytic	NULL
activity	NULL
exclusively	NULL
on	NULL
Ad-infected	NULL
or	NULL
Ad-transformed	NULL
cells	NULL
.	NULL

E1A	NULL
genetic	NULL
mapping	NULL
studies	NULL
(	NULL
54	NULL
,	NULL
55	NULL
)	NULL
suggest	NULL
that	NULL
the	NULL
capacity	NULL
of	NULL
E1A	NULL
to	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
depends	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
either	NULL
or	NULL
both	NULL
CR1	NULL
and	NULL
CR2	NULL
of	NULL
ElA	NULL
,	NULL
regions	NULL
homologous	NULL
with	NULL
E7	NULL
oncoprotein	NULL
and	NULL
linked	NULL
to	NULL
many	NULL
of	NULL
their	NULL
shared	NULL
biological	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
first	NULL
series	NULL
of	NULL
NK	NULL
cytolysis	NULL
assays	NULL
determined	NULL
if	NULL
the	NULL
E7	NULL
oncoprotein	NULL
would	NULL
also	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
in	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
E1A	NULL
.	NULL

Because	NULL
HPV	NULL
appear	NULL
to	NULL
infect	NULL
cells	NULL
exclusively	NULL
of	NULL
keratinocyte	NULL
origin	NULL
,	NULL
our	NULL
initial	NULL
studies	NULL
used	NULL
keratinocyte-derived	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
cervical	NULL
cancer	NULL
cell	NULL
lines	NULL
CaSki	NULL
,	NULL
SiHa	NULL
,	NULL
and	NULL
HeLa	NULL
express	NULL
the	NULL
E7	NULL
and	NULL
E6	NULL
genes	NULL
derived	NULL
from	NULL
HPV-16	NULL
(	NULL
CaSki	NULL
and	NULL
SiHa	NULL
)	NULL
or	NULL
HPV-18	NULL
(	NULL
HeLa	NULL
)	NULL
.	NULL

HFK-1321	NULL
and	NULL
18NCO	NULL
are	NULL
human	NULL
epidermal	NULL
keratinocytes	NULL
transformed	NULL
by	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
HPV-16	NULL
E6	NULL
and	NULL
E7	NULL
genes	NULL
expressed	NULL
from	NULL
a	NULL
human	NULL
B-actin	NULL
promoter	NULL
(	NULL
HFK-1321	NULL
)	NULL
or	NULL
the	NULL
full	NULL
HPV-18	NULL
genome	NULL
linearized	NULL
at	NULL
a	NULL
unique	NULL
Nco	NULL
!	NULL

site	NULL
(	NULL
18NCO	NULL
)	NULL
.	NULL

Cells	NULL
either	NULL
naturally	NULL
transformed	NULL
by	NULL
HPV	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
or	NULL
transformed	NULL
by	NULL
transfection	NULL
with	NULL
HPV	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
were	NULL
sensitive	NULL
to	NULL
lysis	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
these	NULL
HPV-transformed	NULL
cell	NULL
lines	NULL
by	NULL
IFN-y	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
reduction	NULL
of	NULL
NK	NULL
cell	NULL
killing	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
magnitude	NULL
of	NULL
the	NULL
IFN-induced	NULL
reduction	NULL
in	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
HPV	NULL
-transformed	NULL
cell	NULL
lines	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
reduction	NULL
measured	NULL
with	NULL
A431	NULL
,	NULL
a	NULL
non-HPV-expressing	NULL
vulvar	NULL
carcinoma	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
cytolytic	NULL
resistance	NULL
in	NULL
keratinocyte-derived	NULL
cell	NULL
lines	NULL
by	NULL
E1A	NULL
is	NULL
expression	NULL
level	NULL
dependent	NULL
.	NULL

The	NULL
next	NULL
series	NULL
of	NULL
experiments	NULL
compared	NULL
the	NULL
abilities	NULL
of	NULL
E7	NULL
and	NULL
E1A	NULL
to	NULL
block	NULL
cytolytic	NULL
resistance	NULL
in	NULL
a	NULL
keratinocyte-derived	NULL
cell	NULL
line	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
if	NULL
there	NULL
was	NULL
a	NULL
relationship	NULL
between	NULL
the	NULL
level	NULL
of	NULL
E1A	NULL
expression	NULL
and	NULL
the	NULL
magnitude	NULL
by	NULL
which	NULL
E1A	NULL
blocks	NULL
IFN	NULL
's	NULL
NK	NULL
LYSIS	NULL
OF	NULL
HPV-	NULL
AND	NULL
Ad-TRANSFORMED	NULL
CELLS	NULL
7641	NULL
A	NULL
so	NULL
€	NULL
e	NULL
§	NULL
°	NULL
-M-	NULL
CaSki	NULL
3	NULL
-L-	NULL
CaSki-IFN	NULL
a0	NULL
-O-	NULL
SiHa	NULL
3	NULL
-O-	NULL
SiHa-IFN	NULL
5	NULL
-	NULL
&	NULL
-	NULL
Hela	NULL
E	NULL
20	NULL
-A-	NULL
HeLa-IFN	NULL
g	NULL
£	NULL
I	NULL
E	NULL
0	NULL
60	NULL
ar	NULL
zs	NULL
so	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
B	NULL
_	NULL
80	NULL
&	NULL
9	NULL
so	NULL
-E-	NULL
HFK-4321	NULL
A	NULL
-C-	NULL
HFK-A1321-IFN	NULL
3	NULL
-e-	NULL
isNCO	NULL
Ao	NULL
ap	NULL
-O-	NULL
18NCO-IFN	NULL
a	NULL
-	NULL
&	NULL
-	NULL
A431	NULL
ha	NULL
-A-	NULL
Ad431-IFN	NULL
m	NULL
fol	NULL
m	NULL
a	NULL
=	NULL
6	NULL
12	NULL
.	NULL

25	NULL
50	NULL
-	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

IFN-activated	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
HPV-transformed	NULL
,	NULL
keratinocyte-derived	NULL
cells	NULL
.	NULL

Effector	NULL
:	NULL
target	NULL
ratio	NULL
indicates	NULL
the	NULL
ratio	NULL
of	NULL
IFN-activated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
to	NULL
targets	NULL
cells	NULL
.	NULL

Target	NULL
cell	NULL
killing	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
)	NULL
of	NULL
NK	NULL
cell-induced	NULL
release	NULL
of	NULL
incorporated	NULL
**Cr	NULL
from	NULL
target	NULL
cells	NULL
in	NULL
four	NULL
4-h	NULL
cytolysis	NULL
assays	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NK	NULL
cell	NULL
lysis	NULL
of	NULL
IFN-y-treated	NULL
(	NULL
open	NULL
squares	NULL
,	NULL
circles	NULL
,	NULL
and	NULL
triangles	NULL
)	NULL
and	NULL
untreated	NULL
(	NULL
closed	NULL
squares	NULL
,	NULL
circles	NULL
,	NULL
and	NULL
triangles	NULL
)	NULL
HPV-16-	NULL
(	NULL
CaSki	NULL
and	NULL
SiHa	NULL
)	NULL
or	NULL
HPV-18	NULL
(	NULL
HeLa	NULL
)	NULL
-transformed	NULL
cervical	NULL
cancer	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
by	NULL
IFN-y	NULL
on	NULL
HPV-expressing	NULL
(	NULL
HFK-1321	NULL
and	NULL
18	NULL
NCO	NULL
)	NULL
or	NULL
non-HPV-expressing	NULL
(	NULL
A431	NULL
)	NULL
human	NULL
keratinocyte-derived	NULL
cell	NULL
lines	NULL
.	NULL

induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
.	NULL

IC4	NULL
is	NULL
a	NULL
HeLa	NULL
$	NULL
3	NULL
cell	NULL
line	NULL
transfected	NULL
with	NULL
the	NULL
Ad2	NULL
E1A	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
murine	NULL
mammary	NULL
tumor	NULL
virus	NULL
promoter	NULL
.	NULL

IC4-D10	NULL
is	NULL
a	NULL
subclone	NULL
of	NULL
IC4	NULL
obtained	NULL
by	NULL
limiting	NULL
dilution	NULL
in	NULL
which	NULL
the	NULL
level	NULL
of	NULL
E1A	NULL
induced	NULL
is	NULL
dexamethasone	NULL
concentration	NULL
dependent	NULL
and	NULL
which	NULL
exhibits	NULL
strict	NULL
dexamethasone	NULL
inducibility	NULL
;	NULL
there	NULL
is	NULL
no	NULL
expression	NULL
of	NULL
ElA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenous	NULL
dexamethasone	NULL
,	NULL
with	NULL
100	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
expressing	NULL
E1A	NULL
following	NULL
treatment	NULL
with	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
for	NULL
24	NULL
h	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Initial	NULL
experiments	NULL
determined	NULL
if	NULL
IFN-y	NULL
treatment	NULL
altered	NULL
the	NULL
levels	NULL
of	NULL
E1A	NULL
proteins	NULL
induced	NULL
following	NULL
stimulation	NULL
of	NULL
IC4-D10	NULL
cells	NULL
with	NULL
dexamethasone	NULL
.	NULL

Previous	NULL
studies	NULL
show	NULL
that	NULL
incubation	NULL
of	NULL
IC4-D10	NULL
cells	NULL
with	NULL
dexamethasone	NULL
induces	NULL
E1A	NULL
expression	NULL
in	NULL
a	NULL
time-dependent	NULL
manner	NULL
,	NULL
with	NULL
maximal	NULL
levels	NULL
of	NULL
E1A	NULL
protein	NULL
present	NULL
following	NULL
5-day	NULL
dexamethasone	NULL
treatment	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
IC4-D10	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~©	NULL
,	NULL
10~	NULL
``	NULL
,	NULL
10~°	NULL
,	NULL
and	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
5	NULL
days	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
16	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
in	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
dexamethasone	NULL
)	NULL
.	NULL

E1A	NULL
expression	NULL
was	NULL
measured	NULL
by	NULL
Western	NULL
analysis	NULL
using	NULL
monoclonal	NULL
antibody	NULL
M73	NULL
.	NULL

E1A	NULL
protein	NULL
levels	NULL
in	NULL
dexamethasone-stimulated	NULL
IC4-D10	NULL
cells	NULL
were	NULL
unaffected	NULL
by	NULL
IFN-y	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Dexamethasone	NULL
induced	NULL
E1A	NULL
protein	NULL
expression	NULL
in	NULL
IFN-y	NULL
treated	NULL
IC4-D10	NULL
cells	NULL
in	NULL
a	NULL
concentration-depen-dent	NULL
manner	NULL
.	NULL

Dexamethasone	NULL
at	NULL
10~°	NULL
M	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
or	NULL
10~	NULL
'	NULL
M	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
induced	NULL
maximal	NULL
,	NULL
equivalent	NULL
levels	NULL
of	NULL
E1A	NULL
proteins	NULL
in	NULL
IC4-D10	NULL
cells	NULL
,	NULL
whereas	NULL
only	NULL
trace	NULL
amounts	NULL
of	NULL
E1A	NULL
could	NULL
be	NULL
detected	NULL
following	NULL
incubation	NULL
with	NULL
10~°	NULL
M	NULL
dexameth-	NULL
7642	NULL
ROUTES	NULL
AND	NULL
RYAN	NULL
DEX	NULL
10-6	NULL
M	NULL
,	NULL
IFN	NULL
DEX	NULL
10°	NULL
M	NULL
,	NULL
IFN	NULL
DEX	NULL
108	NULL
M	NULL
,	NULL
IFN	NULL
DEX	NULL
10-5	NULL
M	NULL
1C4-D10	NULL
M	NULL
Bel	NULL
e	NULL
sl	NULL
'	NULL
<	NULL
-E1A	NULL
wan	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
E1A	NULL
expression	NULL
in	NULL
IC4-D10	NULL
cells	NULL
by	NULL
dexamethasone	NULL
.	NULL

IC4-D10	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dexamethasone	NULL
(	NULL
DEX	NULL
;	NULL
10	NULL
5	NULL
,	NULL
10-8	NULL
,	NULL
or	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
5	NULL
days	NULL
to	NULL
induce	NULL
E1A	NULL
expression	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
16	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
in	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
dexamethasone	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
E1A	NULL
protein	NULL
expressed	NULL
in	NULL
IC4-D10	NULL
cells	NULL
was	NULL
then	NULL
assessed	NULL
by	NULL
Western	NULL
analysis	NULL
and	NULL
compared	NULL
with	NULL
the	NULL
level	NULL
in	NULL
Ad5	NULL
E1-transformed	NULL
human	NULL
embryonic	NULL
kidney	NULL
cell	NULL
line	NULL
293.	NULL
asone	NULL
upon	NULL
prolonged	NULL
exposure	NULL
of	NULL
the	NULL
autoradiograph	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
agreed	NULL
with	NULL
our	NULL
previously	NULL
published	NULL
results	NULL
for	NULL
IFN-untreated	NULL
,	NULL
dexamethasone-stimulated	NULL
IC4-D10	NULL
cells	NULL
(	NULL
58	NULL
)	NULL
.	NULL

NK	NULL
cell	NULL
cytolysis	NULL
assays	NULL
showed	NULL
that	NULL
dexamethasone	NULL
treatment	NULL
(	NULL
107°	NULL
M	NULL
for	NULL
5	NULL
days	NULL
)	NULL
of	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
ability	NULL
of	NULL
IFN	NULL
to	NULL
induce	NULL
cytolytic	NULL
resistance	NULL
to	NULL
NK	NULL
cell	NULL
lysis	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Control	NULL
experiments	NULL
were	NULL
also	NULL
performed	NULL
with	NULL
dexamethasone-treated	NULL
and	NULL
untreated	NULL
G418-resistant	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
(	NULL
HeLa	NULL
S3-neo	NULL
)	NULL
or	NULL
HeLa	NULL
cells	NULL
stably	NULL
expressing	NULL
both	NULL
the	NULL
HIV-1	NULL
envelope	NULL
gene	NULL
and	NULL
G418	NULL
resistance	NULL
(	NULL
HeLa	NULL
c-env	NULL
)	NULL
,	NULL
with	NULL
equivalent	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
A	NULL
100	NULL
€	NULL
y	NULL
so	NULL
5	NULL
-B-	NULL
HeLa-DEX	NULL
3	NULL
-C-	NULL
HeLa-DEX-IFN	NULL
m	NULL
-	NULL
60	NULL
-	NULL
@	NULL
-	NULL
1C4	NULL
3	NULL
-O-	NULL
1C4-IFN	NULL
5	NULL
-	NULL
a	NULL
-A-	NULL
1C4-DEX	NULL
5	NULL
-	NULL
&	NULL
-	NULL
1C4-DEX-IFN	NULL
3	NULL
4	NULL
2	NULL
»	NULL
E	NULL
0	NULL
60	NULL
20	NULL
as	NULL
50	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
B	NULL
so	NULL
9	NULL
&	NULL
Z	NULL
60	NULL
3	NULL
-I-	NULL
1C4	NULL
(	NULL
6	NULL
)	NULL
DEX	NULL
e	NULL
]	NULL
-M-	NULL
-	NULL
1C4	NULL
(	NULL
6	NULL
)	NULL
DEX-IFN	NULL
80	NULL
ay	NULL
-A-	NULL
1C4	NULL
(	NULL
-8	NULL
)	NULL
DEX-IFN	NULL
a	NULL
-A-	NULL
1C4	NULL
(	NULL
-9	NULL
)	NULL
DEX-IFN	NULL
2	NULL
-e	NULL
@	NULL
-	NULL
IC4-IFN	NULL
3	NULL
9	NULL
a	NULL
»	NULL
<	NULL
=	NULL
6	NULL
12	NULL
25	NULL
-	NULL
50	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

IFN-activated	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
E1A-expressing	NULL
,	NULL
keratinocyte-derived	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HeLa	NULL
or	NULL
IC4-D10	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
(	NULL
DEX	NULL
)	NULL
for	NULL
5	NULL
days	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
16	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
in	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
dexamethasone	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
used	NULL
as	NULL
targets	NULL
in	NULL
standard	NULL
4-h	NULL
cytolysis	NULL
assays	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IC4-D10	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~	NULL
%	NULL
,	NULL
10-8	NULL
,	NULL
and	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
5	NULL
days	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
16	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
in	NULL
the	NULL
continued	NULL
presence	NULL
of	NULL
dexamethasone	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
used	NULL
as	NULL
targets	NULL
in	NULL
standard	NULL
4-h	NULL
cytolysis	NULL
assays	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

80	NULL
-M-	NULL
ma	NULL
-O-	NULL
H4-4FN	NULL
-=-	NULL
P2AHTIA	NULL
-*-	NULL
_	NULL
P2AHTA-IFN	NULL
40	NULL
--	NULL
H4.E7	NULL
CLL	NULL
-O-	NULL
-	NULL
H4-E7	NULL
CL1IFN	NULL
20	NULL
-	NULL
&	NULL
-	NULL
H4-E7CL2	NULL
-A-	NULL
H4-E7	NULL
CL2-IFN	NULL
60	NULL
TARGET	NULL
CELL	NULL
KILLING	NULL
(	NULL
%	NULL
)	NULL
6	NULL
12	NULL
25	NULL
50	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
80	NULL
60	NULL
-E-	NULL
wis	NULL
-O-	NULL
wras4rn	NULL
-*-	NULL
cn2	NULL
40	NULL
-O-	NULL
CL2IFN	NULL
CL4	NULL
20	NULL
-A-	NULL
_	NULL
CL4IFN	NULL
6	NULL
12	NULL
25	NULL
-	NULL
50	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
TARGET	NULL
CELL	NULL
KILLING	NULL
(	NULL
%	NULL
)	NULL
&	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

IFN-activated	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
E7-	NULL
or	NULL
E1A-expressing	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparison	NULL
of	NULL
the	NULL
cytolytic	NULL
resistance	NULL
induced	NULL
by	NULL
IFN-y	NULL
on	NULL
the	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
H4	NULL
,	NULL
E1A-transfected	NULL
H4	NULL
cells	NULL
(	NULL
P2AHT2A	NULL
)	NULL
,	NULL
or	NULL
HPV-16	NULL
E7-transfected	NULL
H4	NULL
cells	NULL
(	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
by	NULL
IFN-y	NULL
on	NULL
the	NULL
normal	NULL
diploid	NULL
fibroblast	NULL
cell	NULL
line	NULL
WI-38	NULL
and	NULL
HPV-16-transformed	NULL
WI-38	NULL
cells	NULL
(	NULL
CL2	NULL
and	NULL
CL4	NULL
)	NULL
.	NULL

of	NULL
E1A	NULL
gene	NULL
products	NULL
in	NULL
dexamethasone-treated	NULL
IC4-D10	NULL
cells	NULL
blocked	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
magnitudes	NULL
by	NULL
which	NULL
IFN	NULL
reduced	NULL
NK	NULL
cell	NULL
killing	NULL
were	NULL
compared	NULL
in	NULL
IC4-D10	NULL
cells	NULL
stimulated	NULL
with	NULL
10	NULL
%	NULL
,	NULL
10	NULL
``	NULL
,	NULL
or	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
.	NULL

These	NULL
cytolysis	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
E1A	NULL
levels	NULL
measured	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
demonstrated	NULL
that	NULL
the	NULL
extent	NULL
to	NULL
which	NULL
E1A	NULL
inhibited	NULL
cytolytic	NULL
resistance	NULL
was	NULL
proportional	NULL
to	NULL
the	NULL
level	NULL
of	NULL
E1A	NULL
expression	NULL
.	NULL

E1A	NULL
but	NULL
not	NULL
E7	NULL
expression	NULL
blocks	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
in	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
previous	NULL
experiments	NULL
used	NULL
either	NULL
cancer	NULL
cell	NULL
lines	NULL
naturally	NULL
transformed	NULL
by	NULL
HPV	NULL
or	NULL
primary	NULL
human	NULL
keratinocytes	NULL
transformed	NULL
through	NULL
the	NULL
use	NULL
of	NULL
plasmids	NULL
expressing	NULL
the	NULL
E7	NULL
and	NULL
E6	NULL
genes	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
parental	NULL
cell	NULL
is	NULL
of	NULL
keratinocyte	NULL
origin	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
the	NULL
E6	NULL
oncoprotein	NULL
or	NULL
keratinocyte-specific	NULL
factors	NULL
interfered	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
E7	NULL
oncoprotein	NULL
to	NULL
block	NULL
cytolytic	NULL
resistance	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
and	NULL
to	NULL
further	NULL
compare	NULL
the	NULL
abilities	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
to	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
,	NULL
cytolysis	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
the	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
H4	NULL
,	NULL
E1	NULL
A-transfected	NULL
H4	NULL
cells	NULL
(	NULL
P2AHT2A	NULL
)	NULL
,	NULL
and	NULL
HPV-16	NULL
E7-transfected	NULL
H4	NULL
cells	NULL
(	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
construction	NULL
of	NULL
the	NULL
H4-E7	NULL
cell	NULL
lines	NULL
)	NULL
.	NULL

IFN-y	NULL
treatment	NULL
of	NULL
H4	NULL
cells	NULL
and	NULL
E7-transfected	NULL
H4	NULL
cells	NULL
resulted	NULL
in	NULL
equivalent	NULL
,	NULL
approximately	NULL
50	NULL
%	NULL
reductions	NULL
in	NULL
killing	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
in	NULL
comparison	NULL
with	NULL
untreated	NULL
con-trols	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
no	NULL
consistent	NULL
reduction	NULL
in	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
IFN-y-treated	NULL
P2AHT2A	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
to	NULL
determine	NULL
if	NULL
HPV	NULL
E7	NULL
expression	NULL
had	NULL
any	NULL
effect	NULL
in	NULL
blocking	NULL
cytolytic	NULL
resistance	NULL
in	NULL
normal	NULL
,	NULL
diploid	NULL
fibroblastic	NULL
cells	NULL
,	NULL
WI-38	NULL
cells	NULL
were	NULL
transformed	NULL
by	NULL
transfection	NULL
with	NULL
pLSXN16E6/16E7	NULL
.	NULL

Two	NULL
colonies	NULL
from	NULL
separate	NULL
plates	NULL
were	NULL
randomly	NULL
selected	NULL
,	NULL
cloned	NULL
by	NULL
limiting	NULL
dilution	NULL
,	NULL
and	NULL
used	NULL
in	NULL
subsequent	NULL
NK	NULL
cytolysis	NULL
assays	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
WI-38-E7	NULL
A	NULL
a	NULL
a	NULL
<	NULL
c	NULL
uw	NULL
m	NULL
co	NULL
'	NULL
<	NULL
T	NULL
3	NULL
Z	NULL
i	NULL
©	NULL
x	NULL
ej	NULL
O	NULL
#	NULL
a	NULL
[	NULL
re	NULL
A	NULL
4	NULL
O	NULL
IC	NULL
O	NULL
o	NULL
ey	NULL
M	NULL
-F	NULL
--	NULL
A	NULL
-D	NULL
#	NULL
]	NULL
<	NULL
-E7	NULL
©	NULL
#	NULL
``	NULL
~	NULL
H4-E7	NULL
B	NULL
T2	NULL
ad	NULL
Q0	NULL
Bo	NULL
s	NULL
#	NULL
-	NULL
06	NULL
6	NULL
C	NULL
st	NULL
G	NULL
«	NULL
-I	NULL
-I	NULL
pI	NULL
_O	NULL
4	NULL
]	NULL
O	NULL
®	NULL
eny	NULL
CAC	NULL
-ACC	NULL
A	NULL
a	NULL
db	NULL
an	NULL
aw	NULL
aw	NULL
san	NULL
«	NULL
--	NULL
-	NULL
--	NULL
-CT	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

HPV-16	NULL
E7	NULL
protein	NULL
levels	NULL
in	NULL
HPV-16-transformed	NULL
keratinocyte-derived	NULL
and	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
.	NULL

CaSki	NULL
,	NULL
HFK-1321	NULL
,	NULL
and	NULL
WI-38-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
(	NULL
A	NULL
)	NULL
or	NULL
SiHa	NULL
and	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IFN-y	NULL
for	NULL
16	NULL
h	NULL
,	NULL
and	NULL
levels	NULL
of	NULL
HPV-16	NULL
E7	NULL
oncoprotein	NULL
were	NULL
measured	NULL
by	NULL
Western	NULL
analysis	NULL
.	NULL

The	NULL
use	NULL
of	NULL
CaSki	NULL
cells	NULL
in	NULL
each	NULL
immunoblot	NULL
allowed	NULL
for	NULL
comparison	NULL
of	NULL
E7	NULL
levels	NULL
between	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

construction	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
)	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
E7	NULL
expression	NULL
did	NULL
not	NULL
effect	NULL
the	NULL
capacity	NULL
of	NULL
IFN	NULL
to	NULL
induce	NULL
cytolytic	NULL
resistance	NULL
,	NULL
with	NULL
equivalent	NULL
reductions	NULL
in	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
IFN-y-treated	NULL
,	NULL
parental	NULL
WI-38	NULL
cells	NULL
and	NULL
HPV-transformed	NULL
WI-38	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
treatment	NULL
of	NULL
E1A-expressing	NULL
keratinocyte-derived	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
or	NULL
fibroblastic	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
cells	NULL
with	NULL
IFN-y	NULL
did	NULL
not	NULL
result	NULL
in	NULL
a	NULL
reduction	NULL
in	NULL
target	NULL
cell	NULL
killing	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN	NULL
induced	NULL
equivalent	NULL
,	NULL
two-	NULL
to	NULL
fourfold	NULL
reductions	NULL
in	NULL
the	NULL
NK	NULL
cell	NULL
lysis	NULL
of	NULL
E7-expressing	NULL
and	NULL
non-HPV	NULL
(	NULL
non-viral	NULL
oncogene	NULL
)	NULL
-expressing	NULL
keratinocyte-derived	NULL
or	NULL
fibroblastic	NULL
cells	NULL
.	NULL

Because	NULL
the	NULL
ability	NULL
of	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
to	NULL
selectively	NULL
lyse	NULL
virally	NULL
transformed	NULL
cells	NULL
depends	NULL
on	NULL
a	NULL
preferential	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
on	NULL
nontransformed	NULL
cells	NULL
,	NULL
the	NULL
inability	NULL
of	NULL
E7	NULL
to	NULL
block	NULL
cytolytic	NULL
resistance	NULL
precludes	NULL
the	NULL
selective	NULL
lysis	NULL
of	NULL
HPV-transformed	NULL
cells	NULL
by	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
.	NULL

Effect	NULL
of	NULL
IFN-y	NULL
treatment	NULL
on	NULL
E7	NULL
expression	NULL
in	NULL
E7-expressing	NULL
fibroblastic	NULL
and	NULL
keratinocyte-derived	NULL
cell	NULL
lines	NULL
.	NULL

IFN-y	NULL
treatment	NULL
of	NULL
some	NULL
HPV-transformed	NULL
human	NULL
cervical	NULL
cancer	NULL
cell	NULL
lines	NULL
can	NULL
decrease	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
E7	NULL
and	NULL
E6	NULL
oncoproteins	NULL
(	NULL
46	NULL
,	NULL
73	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
given	NULL
the	NULL
previously	NULL
established	NULL
relationship	NULL
between	NULL
the	NULL
level	NULL
of	NULL
E1A	NULL
expression	NULL
and	NULL
the	NULL
magnitude	NULL
of	NULL
E1A	NULL
's	NULL
inhibition	NULL
of	NULL
cytolytic	NULL
resistance	NULL
,	NULL
it	NULL
seemed	NULL
possible	NULL
that	NULL
the	NULL
IFN-y-induced	NULL
downregulation	NULL
of	NULL
E7	NULL
expression	NULL
could	NULL
explain	NULL
the	NULL
inability	NULL
of	NULL
E7	NULL
to	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

However	NULL
,	NULL
this	NULL
explanation	NULL
appeared	NULL
unlikely	NULL
because	NULL
many	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
(	NULL
HFK-1321	NULL
,	NULL
WI-38	NULL
E7	NULL
clones	NULL
,	NULL
and	NULL
H4-E7	NULL
clones	NULL
)	NULL
were	NULL
transformed	NULL
by	NULL
plasmids	NULL
in	NULL
which	NULL
E7	NULL
gene	NULL
expression	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
IFN-insensitive	NULL
promoters	NULL
.	NULL

To	NULL
directly	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
E7	NULL
oncoprotein	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
immunoblotting	NULL
in	NULL
the	NULL
HPV-16	NULL
E7-expressing	NULL
human	NULL
cell	NULL
lines	NULL
(	NULL
CaSki	NULL
,	NULL
HFK-1321	NULL
,	NULL
SiHa	NULL
,	NULL
WI-38	NULL
E7	NULL
CL1	NULL
and	NULL
CL2	NULL
,	NULL
and	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
)	NULL
.	NULL

HPV-16	NULL
cell	NULL
lines	NULL
were	NULL
exclusively	NULL
examined	NULL
because	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
commercially	NULL
available	NULL
E7	NULL
antibodies	NULL
for	NULL
HPV-18	NULL
.	NULL

IFN-y	NULL
did	NULL
not	NULL
decrease	NULL
E7	NULL
expression	NULL
in	NULL
the	NULL
E7-transfected	NULL
H4	NULL
or	NULL
WI-38	NULL
cells	NULL
,	NULL
CaSki	NULL
cells	NULL
,	NULL
and	NULL
HFK-1321	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
small	NULL
reduction	NULL
was	NULL
seen	NULL
in	NULL
SiHa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
E7	NULL
levels	NULL
differed	NULL
considerably	NULL
among	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

CaSki	NULL
cells	NULL
and	NULL
the	NULL
H4-E7	NULL
clones	NULL
expressed	NULL
extremely	NULL
high	NULL
levels	NULL
of	NULL
E7	NULL
,	NULL
with	NULL
lower	NULL
but	NULL
still	NULL
easily	NULL
detectable	NULL
amounts	NULL
in	NULL
the	NULL
WI-38	NULL
NK	NULL
LYSIS	NULL
OF	NULL
HPV-	NULL
AND	NULL
Ad-TRANSFORMED	NULL
CELLS	NULL
7643	NULL
H4	NULL
-	NULL
E7	NULL
AHT2A	NULL
LONE	NULL
1	NULL
LONE	NULL
2	NULL
%	NULL
R	NULL
s	NULL
a	NULL
IFN-y	NULL
-	NULL
+	NULL
-	NULL
+	NULL
+o	NULL
>	NULL
of	NULL
'	NULL
«	NULL
#	NULL
'-	NULL
'	NULL
Jin	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

E1A	NULL
but	NULL
not	NULL
E7	NULL
blocks	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
to	NULL
transcriptionally	NULL
activate	NULL
IRF-1	NULL
.	NULL

H4	NULL
,	NULL
E1A-transfected	NULL
H4	NULL
(	NULL
P2AHT2A	NULL
)	NULL
,	NULL
and	NULL
E7-transfected	NULL
H4	NULL
(	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
)	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
IFN-y	NULL
(	NULL
5,000	NULL
U/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
IRF-1	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

E7	NULL
clones	NULL
,	NULL
SiHa	NULL
cells	NULL
,	NULL
and	NULL
HFK-1321	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
conjunction	NULL
with	NULL
the	NULL
previously	NULL
shown	NULL
cytolysis	NULL
assays	NULL
,	NULL
these	NULL
immuno-blots	NULL
demonstrated	NULL
that	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
was	NULL
unaffected	NULL
by	NULL
even	NULL
high	NULL
levels	NULL
of	NULL
E7	NULL
expression	NULL
.	NULL

E1A	NULL
but	NULL
not	NULL
E7	NULL
expression	NULL
blocks	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
.	NULL

Previous	NULL
studies	NULL
show	NULL
that	NULL
E1A	NULL
blocks	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
,	NULL
a	NULL
process	NULL
dependent	NULL
on	NULL
the	NULL
inability	NULL
to	NULL
form	NULL
an	NULL
activated	NULL
IFN-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
complex	NULL
in	NULL
E1A-expressing	NULL
cells	NULL
(	NULL
31	NULL
,	NULL
36	NULL
)	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
capacity	NULL
of	NULL
IFN	NULL
to	NULL
induce	NULL
cytolytic	NULL
resistance	NULL
is	NULL
related	NULL
to	NULL
its	NULL
capacity	NULL
to	NULL
transcriptionally	NULL
activate	NULL
selected	NULL
cellular	NULL
genes	NULL
(	NULL
IFN-stimu-lated	NULL
genes	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
capacities	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
may	NULL
be	NULL
secondary	NULL
to	NULL
dissimilarities	NULL
in	NULL
their	NULL
respective	NULL
capacities	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
.	NULL

As	NULL
one	NULL
test	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
to	NULL
transcriptionally	NULL
activate	NULL
the	NULL
IRF-1	NULL
gene	NULL
was	NULL
measured	NULL
in	NULL
H4	NULL
,	NULL
P2AHT2A	NULL
,	NULL
and	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
.	NULL

The	NULL
H4-derived	NULL
cell	NULL
lines	NULL
were	NULL
used	NULL
for	NULL
these	NULL
studies	NULL
because	NULL
they	NULL
allowed	NULL
a	NULL
direct	NULL
comparison	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
functions	NULL
in	NULL
the	NULL
same	NULL
parental	NULL
background	NULL
.	NULL

Furthermore	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
E7	NULL
oncoprotein	NULL
were	NULL
present	NULL
in	NULL
the	NULL
H4-E7	NULL
clones	NULL
,	NULL
levels	NULL
unaffected	NULL
by	NULL
IFN-y	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

IRF-1	NULL
was	NULL
chosen	NULL
because	NULL
its	NULL
expression	NULL
is	NULL
tightly	NULL
regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
by	NULL
IFN-y	NULL
,	NULL
with	NULL
low	NULL
mRNA	NULL
levels	NULL
expressed	NULL
in	NULL
the	NULL
uninduced	NULL
,	NULL
basal	NULL
state	NULL
(	NULL
63	NULL
)	NULL
.	NULL

mRNA	NULL
levels	NULL
for	NULL
GAPDH	NULL
,	NULL
a	NULL
constitutively	NULL
expressed	NULL
housekeeping	NULL
gene	NULL
,	NULL
were	NULL
also	NULL
measured	NULL
and	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
H4	NULL
,	NULL
P2ZAHT2A	NULL
,	NULL
and	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
IFN-y	NULL
(	NULL
5,000	NULL
U/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
IRF-1	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
E1A	NULL
gene	NULL
products	NULL
in	NULL
H4	NULL
cells	NULL
(	NULL
PZAHT2A	NULL
)	NULL
markedly	NULL
diminished	NULL
the	NULL
capacity	NULL
of	NULL
IFN-y	NULL
to	NULL
increase	NULL
IRF-1	NULL
gene	NULL
expression	NULL
,	NULL
whereas	NULL
E7	NULL
expression	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
IFN-y	NULL
markedly	NULL
increases	NULL
IRF-1	NULL
gene	NULL
expression	NULL
in	NULL
CaSki	NULL
cells	NULL
,	NULL
SiHa	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
WI-38	NULL
E7	NULL
clones	NULL
(	NULL
55	NULL
)	NULL
.	NULL

E1A	NULL
but	NULL
not	NULL
E7	NULL
expression	NULL
sensitizes	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
show	NULL
that	NULL
stable	NULL
expression	NULL
of	NULL
the	NULL
AdS	NULL
E1A	NULL
gene	NULL
in	NULL
human	NULL
cells	NULL
results	NULL
in	NULL
an	NULL
increased	NULL
cytolytic	NULL
susceptibility	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
or	NULL
cloned	NULL
NK	NULL
cell	NULL
lines	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
next	NULL
determined	NULL
if	NULL
HPV-16	NULL
or	NULL
HPV-18	NULL
E7	NULL
expression	NULL
in	NULL
either	NULL
keratinocyte-derived	NULL
or	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
would	NULL
sensitize	NULL
these	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
and	NULL
compared	NULL
the	NULL
capacities	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
to	NULL
induce	NULL
this	NULL
effect	NULL
.	NULL

Because	NULL
dexamethasone	NULL
altered	NULL
7644	NULL
ROUTES	NULL
AND	NULL
RYAN	NULL
60	NULL
€	NULL
el	NULL
E	NULL
40	NULL
-O-	NULL
CaSki	NULL
E	NULL
-O-	NULL
Hela	NULL
x	NULL
-e-	NULL
mis	NULL
2	NULL
20	NULL
-A-	NULL
SiHa	NULL
=	NULL
5	NULL
2	NULL
¥	NULL
8	NULL
0	NULL
6	NULL
12	NULL
25	NULL
-	NULL
50	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
B	NULL
60	NULL
9	NULL
o	NULL
Z	NULL
3	NULL
40	NULL
a	NULL
4	NULL
-O-	NULL
A431	NULL
aa	NULL
--	NULL
Mi8	NULL
ﬂ	NULL
-A-	NULL
HFK-1321	NULL
m	NULL
ce	NULL
-O-	NULL
i1sNCO	NULL
but	NULL
m	NULL
o	NULL
3	NULL
<	NULL
2	NULL
6	NULL
12	NULL
25	NULL
50	NULL
-	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Lysis	NULL
of	NULL
E7-	NULL
or	NULL
E1A-expressing	NULL
keratinocyte-derived	NULL
cell	NULL
lines	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
.	NULL

Shown	NULL
are	NULL
comparisons	NULL
of	NULL
NK	NULL
cell	NULL
killing	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
experiments	NULL
)	NULL
of	NULL
HPV	NULL
E7-expressing	NULL
cell	NULL
lines	NULL
(	NULL
CaSki	NULL
,	NULL
SiHa	NULL
,	NULL
Hela	NULL
,	NULL
HFK-1321	NULL
,	NULL
and	NULL
18NCO	NULL
)	NULL
,	NULL
E1A-transfected	NULL
HeLa	NULL
cells	NULL
(	NULL
M18	NULL
)	NULL
,	NULL
or	NULL
the	NULL
non-HPV-expressing	NULL
vulvar	NULL
carcinoma	NULL
cell	NULL
line	NULL
A431	NULL
.	NULL

Non-cytokine-activated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
served	NULL
as	NULL
the	NULL
source	NULL
of	NULL
NK	NULL
cells	NULL
for	NULL
these	NULL
assays	NULL
.	NULL

the	NULL
cytolytic	NULL
susceptibility	NULL
of	NULL
untransfected	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
,	NULL
HeLa	NULL
cells	NULL
and	NULL
E1A-transfected	NULL
HeLa	NULL
cells	NULL
(	NULL
M18	NULL
cells	NULL
)	NULL
were	NULL
substituted	NULL
for	NULL
IC4-D10	NULL
cells	NULL
in	NULL
these	NULL
cytolysis	NULL
assays	NULL
.	NULL

HPV-16	NULL
or	NULL
HPV-18-expressing	NULL
cervical	NULL
cancer	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
or	NULL
keratinocytes	NULL
transformed	NULL
by	NULL
plasmids	NULL
containing	NULL
the	NULL
HPV-16	NULL
or	NULL
HPV-18	NULL
E6	NULL
and	NULL
E7	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
were	NULL
resistant	NULL
to	NULL
lysis	NULL
by	NULL
NK	NULL
cells	NULL
,	NULL
with	NULL
levels	NULL
of	NULL
cytolytic	NULL
susceptibility	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
non-HPV-expressing	NULL
epidermoid	NULL
carcinoma	NULL
cell	NULL
line	NULL
A431	NULL
.	NULL

Furthermore	NULL
,	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
and	NULL
WI-38	NULL
E7	NULL
CL2	NULL
and	NULL
CL4	NULL
exhibited	NULL
the	NULL
same	NULL
extent	NULL
of	NULL
cytolytic	NULL
resistance	NULL
as	NULL
control	NULL
parental	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
E1A	NULL
gene	NULL
products	NULL
in	NULL
either	NULL
HeLa	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
or	NULL
H4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
results	NULL
in	NULL
a	NULL
more	NULL
than	NULL
threefold	NULL
increase	NULL
in	NULL
cytolytic	NULL
susceptibility	NULL
compared	NULL
with	NULL
parental	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Experiments	NULL
reported	NULL
here	NULL
showed	NULL
differences	NULL
in	NULL
the	NULL
capacities	NULL
of	NULL
E1A	NULL
and	NULL
E7	NULL
oncoproteins	NULL
to	NULL
target	NULL
cells	NULL
for	NULL
lysis	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
E1A	NULL
,	NULL
E7	NULL
expression	NULL
neither	NULL
increased	NULL
the	NULL
cytolytic	NULL
susceptibility	NULL
of	NULL
target	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
NK	NULL
cells	NULL
nor	NULL
blocked	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
both	NULL
of	NULL
these	NULL
functions	NULL
,	NULL
which	NULL
are	NULL
present	NULL
in	NULL
E1A	NULL
and	NULL
absent	NULL
in	NULL
E7	NULL
,	NULL
represent	NULL
unique	NULL
activities	NULL
encoded	NULL
by	NULL
distinct	NULL
regions	NULL
of	NULL
E1A	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
based	NULL
on	NULL
the	NULL
following	NULL
observations	NULL
.	NULL

Studies	NULL
using	NULL
rodent	NULL
cells	NULL
show	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
first	NULL
exon	NULL
of	NULL
E1A	NULL
is	NULL
insufficient	NULL
to	NULL
induce	NULL
susceptibility	NULL
to	NULL
NK	NULL
cells	NULL
lysis	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
E1A	NULL
first	NULL
exon	NULL
in	NULL
human	NULL
cells	NULL
blocks	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Human	NULL
cell	NULL
lines	NULL
transformed	NULL
by	NULL
Ad	NULL
or	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
E1A	NULL
gene	NULL
are	NULL
susceptible	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
,	NULL
J.	NULL
ViroL	NULL
.	NULL

A	NULL
50	NULL
€	NULL
u	NULL
40	NULL
f	NULL
&	NULL
H	NULL
E	NULL
30	NULL
-O-	NULL
H4	NULL
4	NULL
-	NULL
#	NULL
-	NULL
P2AHT2A	NULL
3	NULL
20	NULL
-O-	NULL
H4R7CLL	NULL
o	NULL
-A-	NULL
H4R7CL2	NULL
&	NULL
10	NULL
M	NULL
9	NULL
S	NULL
<	NULL
E	NULL
0	NULL
6	NULL
12	NULL
25	NULL
50	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
€	NULL
g	NULL
40	NULL
3	NULL
4G	NULL
--	NULL
P2AHTIA	NULL
a	NULL
30	NULL
-O-	NULL
wass	NULL
a	NULL
-O-	NULL
wihss	NULL
CL2	NULL
5	NULL
20	NULL
-A-	NULL
wis	NULL
CL4	NULL
bat	NULL
&	NULL
10	NULL
$	NULL
2	NULL
?	NULL

``	NULL
o	NULL
o	NULL
6	NULL
12	NULL
25	NULL
50	NULL
-	NULL
100	NULL
EFFECTOR	NULL
:	NULL
TARGET	NULL
RATIO	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Lysis	NULL
of	NULL
E7-	NULL
or	NULL
E1A-expressing	NULL
fibroblastic	NULL
cell	NULL
lines	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
.	NULL

Shown	NULL
are	NULL
comparisons	NULL
of	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
the	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
H4	NULL
,	NULL
E1A-transfected	NULL
H4	NULL
cells	NULL
(	NULL
P2AHT2A	NULL
)	NULL
,	NULL
and	NULL
HPV-16	NULL
E7-transfected	NULL
H4	NULL
cells	NULL
(	NULL
H4-E7	NULL
CL1	NULL
and	NULL
CL2	NULL
)	NULL
(	NULL
A	NULL
)	NULL
and	NULL
of	NULL
WI-38	NULL
cells	NULL
and	NULL
HPV-16-transformed	NULL
WI-38	NULL
cells	NULL
(	NULL
WI-38	NULL
CL2	NULL
and	NULL
CL4	NULL
)	NULL
(	NULL
B	NULL
)	NULL
.	NULL

whereas	NULL
Ad-infected	NULL
human	NULL
cells	NULL
are	NULL
resistant	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
E1A	NULL
gene	NULL
products	NULL
in	NULL
either	NULL
Ad-infected	NULL
,	NULL
Ad-transformed	NULL
,	NULL
or	NULL
E1A-transfected	NULL
human	NULL
cells	NULL
blocks	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
E1A	NULL
to	NULL
block	NULL
IFN	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
is	NULL
related	NULL
to	NULL
E1A	NULL
's	NULL
capacity	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
(	NULL
1	NULL
,	NULL
31	NULL
,	NULL
36	NULL
)	NULL
.	NULL

It	NULL
seems	NULL
unlikely	NULL
that	NULL
the	NULL
capacity	NULL
of	NULL
E1A	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
based	NULL
on	NULL
the	NULL
inability	NULL
to	NULL
form	NULL
an	NULL
activated	NULL
IFN-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
complex	NULL
in	NULL
IFN-stimulated	NULL
cells	NULL
(	NULL
31	NULL
,	NULL
36	NULL
)	NULL
,	NULL
would	NULL
also	NULL
be	NULL
related	NULL
to	NULL
E1A	NULL
's	NULL
induction	NULL
of	NULL
cytolytic	NULL
susceptibility	NULL
.	NULL

It	NULL
is	NULL
this	NULL
latter	NULL
activity	NULL
of	NULL
E1A	NULL
,	NULL
the	NULL
ability	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
,	NULL
that	NULL
likely	NULL
explains	NULL
the	NULL
dissimilar	NULL
capacity	NULL
of	NULL
IFN	NULL
to	NULL
induce	NULL
the	NULL
selective	NULL
NK	NULL
cell	NULL
lysis	NULL
of	NULL
Ad-	NULL
but	NULL
not	NULL
HPV-transformed	NULL
cells	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
to	NULL
kill	NULL
virally	NULL
transformed	NULL
cells	NULL
rests	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
IFN	NULL
to	NULL
induce	NULL
cytolytic	NULL
resistance	NULL
on	NULL
normal	NULL
but	NULL
not	NULL
virally	NULL
transformed	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Because	NULL
E7	NULL
does	NULL
not	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
,	NULL
cytolytic	NULL
resistance	NULL
is	NULL
induced	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
in	NULL
normal	NULL
cells	NULL
.	NULL

E1A	NULL
genetic	NULL
mapping	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
E1A	NULL
to	NULL
bind	NULL
the	NULL
cellular	NULL
protein	NULL
p300	NULL
correlates	NULL
with	NULL
E1A	NULL
's	NULL
capacity	NULL
to	NULL
block	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
and	NULL
cytolytic	NULL
resistance	NULL
(	NULL
55	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
we	NULL
and	NULL
other	NULL
investigators	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
show	NULL
that	NULL
E7	NULL
binds	NULL
p300	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
E7	NULL
to	NULL
block	NULL
cytolytic	NULL
resistance	NULL
and	NULL
IFN-stimulated	NULL
gene	NULL
expression	NULL
is	NULL
secondary	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
E7	NULL
oncoprotein	NULL
to	NULL
bind	NULL
p300	NULL
.	NULL

Previous	NULL
results	NULL
determining	NULL
the	NULL
sensitivity	NULL
of	NULL
HPV-transformed	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
have	NULL
been	NULL
con-tradictory	NULL
.	NULL

The	NULL
cell	NULL
line	NULL
Sk-v	NULL
,	NULL
an	NULL
HPV-16-transformed	NULL
vulvar	NULL
carcinoma	NULL
,	NULL
is	NULL
sensitive	NULL
to	NULL
NK	NULL
cell	NULL
lysis	NULL
,	NULL
a	NULL
process	NULL
dependent	NULL
on	NULL
activation	NULL
of	NULL
NK	NULL
cells	NULL
secondary	NULL
to	NULL
tumor	NULL
cell	NULL
release	NULL
of	NULL
IL-6	NULL
Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Furbert-Harris	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
human	NULL
cervical	NULL
epithelial	NULL
cells	NULL
isolated	NULL
from	NULL
two	NULL
separate	NULL
individuals	NULL
and	NULL
then	NULL
immortalized	NULL
by	NULL
HPV-16	NULL
remained	NULL
resistant	NULL
to	NULL
lysis	NULL
by	NULL
non-cytokine-activated	NULL
NK	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
Furbert-Harris	NULL
et	NULL
al	NULL
.	NULL

and	NULL
suggest	NULL
that	NULL
the	NULL
observation	NULL
regarding	NULL
the	NULL
Sk-v	NULL
cell	NULL
line	NULL
is	NULL
the	NULL
exception	NULL
rather	NULL
than	NULL
the	NULL
rule	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
a	NULL
consistent	NULL
relationship	NULL
between	NULL
the	NULL
capacity	NULL
of	NULL
a	NULL
virus	NULL
to	NULL
transform	NULL
cells	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
oncogenicity	NULL
of	NULL
either	NULL
the	NULL
virus	NULL
or	NULL
the	NULL
virally	NULL
transformed	NULL
cells	NULL
in	NULL
vivo	NULL
is	NULL
a	NULL
well-known	NULL
but	NULL
poorly	NULL
understood	NULL
phenomenon	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
papovavirus	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
can	NULL
transform	NULL
cells	NULL
from	NULL
a	NULL
number	NULL
of	NULL
species	NULL
,	NULL
including	NULL
rodents	NULL
,	NULL
primates	NULL
,	NULL
and	NULL
humans	NULL
,	NULL
but	NULL
is	NULL
oncogenic	NULL
in	NULL
only	NULL
Syrian	NULL
hamsters	NULL
,	NULL
mastomys	NULL
,	NULL
and	NULL
perhaps	NULL
humans	NULL
(	NULL
3	NULL
,	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Group	NULL
A	NULL
(	NULL
Ad12	NULL
)	NULL
and	NULL
group	NULL
C	NULL
(	NULL
Ad2	NULL
and	NULL
Ad5	NULL
)	NULL
Ad	NULL
can	NULL
transform	NULL
cells	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
species	NULL
,	NULL
including	NULL
rodents	NULL
and	NULL
humans	NULL
;	NULL
however	NULL
,	NULL
only	NULL
group	NULL
A	NULL
Ad	NULL
is	NULL
oncogenic	NULL
in	NULL
immunocompetent	NULL
rodents	NULL
,	NULL
and	NULL
neither	NULL
group	NULL
is	NULL
oncogenic	NULL
in	NULL
humans	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
the	NULL
adequacy	NULL
of	NULL
the	NULL
host	NULL
immune	NULL
response	NULL
to	NULL
eliminate	NULL
virally	NULL
transformed	NULL
cells	NULL
must	NULL
be	NULL
critically	NULL
important	NULL
in	NULL
determining	NULL
the	NULL
oncogenicity	NULL
of	NULL
a	NULL
transformation-competent	NULL
virus	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
supported	NULL
by	NULL
numerous	NULL
studies	NULL
demonstrating	NULL
that	NULL
certain	NULL
viruses	NULL
and	NULL
virally	NULL
transformed	NULL
cells	NULL
are	NULL
oncogenic	NULL
only	NULL
in	NULL
immunodefi-cient	NULL
animals	NULL
.	NULL

The	NULL
cellular	NULL
immune	NULL
response	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
dominant	NULL
host	NULL
defense	NULL
involved	NULL
in	NULL
the	NULL
recognition	NULL
and	NULL
elimination	NULL
of	NULL
virally	NULL
transformed	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
two	NULL
components	NULL
of	NULL
cellular	NULL
immunity	NULL
that	NULL
likely	NULL
act	NULL
synergistically	NULL
in	NULL
clearing	NULL
tumor	NULL
cells	NULL
:	NULL
specific	NULL
cellular	NULL
immunity	NULL
,	NULL
mediated	NULL
primarily	NULL
by	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
nonspecific	NULL
cellular	NULL
immunity	NULL
,	NULL
consisting	NULL
of	NULL
both	NULL
macrophages	NULL
and	NULL
NK	NULL
cells	NULL
.	NULL

Nonspecific	NULL
cellular	NULL
immunity	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
particularly	NULL
important	NULL
role	NULL
in	NULL
the	NULL
elimination	NULL
of	NULL
Ad-	NULL
and	NULL
SV40-transformed	NULL
cells	NULL
.	NULL

A	NULL
number	NULL
of	NULL
studies	NULL
have	NULL
correlated	NULL
the	NULL
cytolytic	NULL
sensitivity	NULL
or	NULL
resistance	NULL
of	NULL
either	NULL
SV40-	NULL
or	NULL
Ad-transformed	NULL
cells	NULL
to	NULL
lysis	NULL
in	NULL
vitro	NULL
by	NULL
either	NULL
macrophages	NULL
and	NULL
NK	NULL
cells	NULL
or	NULL
NK	NULL
cells	NULL
alone	NULL
with	NULL
their	NULL
respective	NULL
tumor-inducing	NULL
capacities	NULL
.	NULL

For	NULL
example	NULL
,	NULL
SV40-transformed	NULL
mouse	NULL
and	NULL
rat	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
not	NULL
tumorigenic	NULL
,	NULL
are	NULL
susceptible	NULL
to	NULL
killing	NULL
by	NULL
both	NULL
activated	NULL
macrophages	NULL
and	NULL
NK	NULL
cells	NULL
,	NULL
whereas	NULL
highly	NULL
tumorigenic	NULL
SV40-transformed	NULL
hamster	NULL
cells	NULL
are	NULL
resistant	NULL
to	NULL
both	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Rodent	NULL
cells	NULL
either	NULL
infected	NULL
or	NULL
transformed	NULL
by	NULL
the	NULL
nononcogenic	NULL
group	NULL
C	NULL
Ad	NULL
are	NULL
sensitive	NULL
to	NULL
both	NULL
macrophage	NULL
and	NULL
NK	NULL
cell	NULL
lysis	NULL
,	NULL
whereas	NULL
cells	NULL
infected	NULL
or	NULL
transformed	NULL
by	NULL
the	NULL
oncogenic	NULL
Ad	NULL
are	NULL
resistant	NULL
NK	NULL
cell	NULL
lysis	NULL
but	NULL
sensitive	NULL
to	NULL
killing	NULL
by	NULL
activated	NULL
macrophages	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
40	NULL
,	NULL
59	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Direct	NULL
evidence	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
NK	NULL
cells	NULL
is	NULL
provided	NULL
by	NULL
observations	NULL
in	NULL
rodents	NULL
showing	NULL
that	NULL
NK	NULL
cells	NULL
can	NULL
reject	NULL
E1A¥-expressing	NULL
sarcoma	NULL
cells	NULL
in	NULL
vivo	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
thymus-dependent	NULL
responses	NULL
(	NULL
15	NULL
,	NULL
72	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
study	NULL
,	NULL
therefore	NULL
,	NULL
are	NULL
consistent	NULL
with	NULL
and	NULL
extend	NULL
to	NULL
HPV	NULL
the	NULL
prior	NULL
observations	NULL
regarding	NULL
SV40	NULL
and	NULL
Ad	NULL
correlating	NULL
NK	NULL
cell	NULL
,	NULL
cytolytic	NULL
susceptibility	NULL
of	NULL
virally	NULL
transformed	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
oncogenicity	NULL
of	NULL
the	NULL
transforming	NULL
virus	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
HPV	NULL
,	NULL
SV40	NULL
and	NULL
many	NULL
polyomaviruses	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
express	NULL
viral	NULL
oncoproteins	NULL
with	NULL
CR1/CR2	NULL
homology	NULL
to	NULL
E1A	NULL
and	NULL
thereby	NULL
interact	NULL
with	NULL
cellular	NULL
proteins	NULL
(	NULL
p105	NULL
and	NULL
p107	NULL
)	NULL
that	NULL
are	NULL
key	NULL
regulators	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
adequacy	NULL
of	NULL
NK	NULL
cells	NULL
to	NULL
mount	NULL
an	NULL
effective	NULL
immunologic	NULL
defense	NULL
against	NULL
this	NULL
group	NULL
of	NULL
DNA	NULL
tumor	NULL
viruses	NULL
is	NULL
an	NULL
important	NULL
factor	NULL
in	NULL
determining	NULL
the	NULL
oncogenicity	NULL
of	NULL
these	NULL
viruses	NULL
in	NULL
their	NULL
immunocompetent	NULL
hosts	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
the	NULL
selective	NULL
killing	NULL
of	NULL
virally	NULL
infected	NULL
or	NULL
virally	NULL
transformed	NULL
cells	NULL
by	NULL
unstimulated	NULL
or	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
actual	NULL
biological	NULL
effects	NULL
of	NULL
these	NULL
NK	NULL
cells	NULL
in	NULL
vivo	NULL
is	NULL
unknown	NULL
.	NULL

Studies	NULL
using	NULL
murine	NULL
cyto-	NULL
NK	NULL
LYSIS	NULL
OF	NULL
HPV-	NULL
AND	NULL
Ad-TRANSFORMED	NULL
CELLS	NULL
7645	NULL
megalovirus	NULL
and	NULL
lymphocytic	NULL
choriomeningitis	NULL
virus	NULL
infection	NULL
of	NULL
rodents	NULL
showed	NULL
that	NULL
the	NULL
IFN-induced	NULL
,	NULL
selective	NULL
killing	NULL
of	NULL
virally	NULL
infected	NULL
cells	NULL
in	NULL
vitro	NULL
mirrors	NULL
the	NULL
antiviral	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
mediated	NULL
in	NULL
vivo	NULL
(	NULL
5	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
unstimulated	NULL
NK	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
studies	NULL
which	NULL
correlated	NULL
the	NULL
oncogenicity	NULL
of	NULL
group	NULL
A	NULL
and	NULL
group	NULL
C	NULL
Ad	NULL
in	NULL
vivo	NULL
with	NULL
the	NULL
cytolytic	NULL
susceptibility	NULL
of	NULL
group	NULL
A	NULL
and	NULL
group	NULL
C	NULL
Ad-transformed	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
used	NULL
both	NULL
IFN-activated	NULL
and	NULL
unstimulated	NULL
NK	NULL
cells	NULL
in	NULL
our	NULL
cytolysis	NULL
assays	NULL
in	NULL
an	NULL
effort	NULL
to	NULL
best	NULL
approximate	NULL
the	NULL
lytic	NULL
activities	NULL
of	NULL
NK	NULL
cells	NULL
that	NULL
may	NULL
be	NULL
present	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
part	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
results	NULL
of	NULL
this	NULL
study	NULL
,	NULL
we	NULL
propose	NULL
the	NULL
following	NULL
model	NULL
to	NULL
help	NULL
explain	NULL
the	NULL
dissimilar	NULL
oncogenicities	NULL
of	NULL
Ad	NULL
and	NULL
HPV	NULL
in	NULL
view	NULL
of	NULL
their	NULL
proclivity	NULL
to	NULL
cause	NULL
persistent	NULL
infections	NULL
and	NULL
capacity	NULL
to	NULL
transform	NULL
cells	NULL
.	NULL

NK	NULL
cells	NULL
are	NULL
a	NULL
component	NULL
of	NULL
the	NULL
inflammatory	NULL
infiltrate	NULL
in	NULL
HPV	NULL
cervical	NULL
infections	NULL
and	NULL
cervical	NULL
epithelial	NULL
neoplasia	NULL
(	NULL
66	NULL
)	NULL
.	NULL

Because	NULL
E7	NULL
expression	NULL
does	NULL
not	NULL
induce	NULL
an	NULL
increase	NULL
in	NULL
cytolytic	NULL
susceptibility	NULL
,	NULL
unstimulated	NULL
NK	NULL
cells	NULL
would	NULL
be	NULL
ineffective	NULL
in	NULL
the	NULL
rejection	NULL
of	NULL
these	NULL
virally	NULL
infected	NULL
or	NULL
transformed	NULL
cells	NULL
.	NULL

HPV-transformed	NULL
cells	NULL
can	NULL
induce	NULL
IFN	NULL
production	NULL
by	NULL
inflammatory	NULL
cells	NULL
in	NULL
vitro	NULL
(	NULL
69	NULL
)	NULL
;	NULL
therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
IFN	NULL
is	NULL
produced	NULL
locally	NULL
in	NULL
vivo	NULL
at	NULL
the	NULL
inflammatory	NULL
interface	NULL
between	NULL
host	NULL
leukocytes	NULL
(	NULL
including	NULL
NK	NULL
cells	NULL
)	NULL
and	NULL
HPV-infected	NULL
or	NULL
transformed	NULL
cells	NULL
.	NULL

Locally	NULL
produced	NULL
IFN	NULL
would	NULL
increase	NULL
the	NULL
lytic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
at	NULL
this	NULL
inflammatory	NULL
site	NULL
.	NULL

However	NULL
,	NULL
this	NULL
effect	NULL
on	NULL
NK	NULL
cells	NULL
would	NULL
be	NULL
negated	NULL
because	NULL
IFN	NULL
would	NULL
induce	NULL
equivalent	NULL
levels	NULL
of	NULL
cytolytic	NULL
resistance	NULL
on	NULL
HPV-infected	NULL
,	NULL
HPV-transformed	NULL
cells	NULL
and	NULL
normal	NULL
cells	NULL
.	NULL

Persistence	NULL
of	NULL
both	NULL
HPV-infected	NULL
and	NULL
HPV-transformed	NULL
cells	NULL
would	NULL
be	NULL
favored	NULL
because	NULL
of	NULL
the	NULL
subversion	NULL
of	NULL
the	NULL
host	NULL
NK	NULL
cell	NULL
response	NULL
.	NULL

Furthermore	NULL
,	NULL
if	NULL
not	NULL
eliminated	NULL
by	NULL
other	NULL
mechanisms	NULL
,	NULL
HPV-transformed	NULL
cells	NULL
could	NULL
then	NULL
acquire	NULL
additional	NULL
somatic	NULL
mutations	NULL
leading	NULL
to	NULL
increased	NULL
virulence	NULL
and	NULL
frank	NULL
malignancy	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
HPV-transformed	NULL
cells	NULL
,	NULL
Ad-transformed	NULL
cells	NULL
are	NULL
susceptible	NULL
to	NULL
killing	NULL
by	NULL
both	NULL
IFN-activated	NULL
and	NULL
unstimulated	NULL
NK	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
IFN	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
Ad	NULL
infection	NULL
(	NULL
51	NULL
)	NULL
or	NULL
constitutively	NULL
produced	NULL
in	NULL
Ad-transformed	NULL
cells	NULL
(	NULL
47	NULL
)	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
enhance	NULL
the	NULL
NK	NULL
cell-mediated	NULL
lysis	NULL
of	NULL
Ad-infected	NULL
or	NULL
transformed	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
Ad	NULL
to	NULL
transform	NULL
cells	NULL
may	NULL
be	NULL
insufficient	NULL
to	NULL
cause	NULL
tumors	NULL
in	NULL
humans	NULL
because	NULL
the	NULL
gene	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
transformation	NULL
(	NULL
E1A	NULL
)	NULL
also	NULL
targets	NULL
the	NULL
cell	NULL
for	NULL
destruction	NULL
by	NULL
the	NULL
host	NULL
NK	NULL
cell	NULL
response	NULL
.	NULL

However	NULL
,	NULL
the	NULL
capacity	NULL
of	NULL
Ad	NULL
to	NULL
cause	NULL
persistent	NULL
infections	NULL
may	NULL
be	NULL
explained	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
resistance	NULL
of	NULL
Ad-infected	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
unstimulated	NULL
NK	NULL
cells	NULL
.	NULL

This	NULL
cytolytic	NULL
resistance	NULL
may	NULL
allow	NULL
for	NULL
the	NULL
replication	NULL
and	NULL
spread	NULL
of	NULL
Ad	NULL
prior	NULL
to	NULL
local	NULL
IFN	NULL
production	NULL
and	NULL
concomitant	NULL
acquisition	NULL
of	NULL
an	NULL
effective	NULL
NK	NULL
cell	NULL
response	NULL
.	NULL

This	NULL
mechanism	NULL
may	NULL
complement	NULL
other	NULL
strategies	NULL
attributed	NULL
to	NULL
Ad	NULL
that	NULL
undermine	NULL
the	NULL
antiviral	NULL
immune	NULL
response	NULL
of	NULL
humans	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
27	NULL
,	NULL
28	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
human	NULL
cells	NULL
expressing	NULL
the	NULL
E7	NULL
oncoprotein	NULL
were	NULL
not	NULL
discriminately	NULL
lysed	NULL
by	NULL
either	NULL
IFN-activated	NULL
NK	NULL
cells	NULL
or	NULL
unstimulated	NULL
NK	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
same	NULL
cells	NULL
expressing	NULL
the	NULL
E1A	NULL
oncoprotein	NULL
were	NULL
differentially	NULL
killed	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
these	NULL
differences	NULL
in	NULL
NK	NULL
cell	NULL
killing	NULL
of	NULL
Ad-	NULL
and	NULL
HPV-transformed	NULL
cells	NULL
reflect	NULL
two	NULL
separate	NULL
functions	NULL
which	NULL
are	NULL
present	NULL
in	NULL
E1A	NULL
and	NULL
absent	NULL
in	NULL
E7	NULL
:	NULL
the	NULL
capacity	NULL
to	NULL
induce	NULL
cytolytic	NULL
susceptibility	NULL
to	NULL
NK	NULL
cell	NULL
lysis	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
block	NULL
the	NULL
induction	NULL
of	NULL
cytolytic	NULL
resistance	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
disparity	NULL
in	NULL
the	NULL
NK	NULL
cell-mediated	NULL
destruction	NULL
of	NULL
Ad-transformed	NULL
compared	NULL
with	NULL
HPV	NULL
human	NULL
cells	NULL
in	NULL
vivo	NULL
contributes	NULL
to	NULL
dissimilar	NULL
oncogenicities	NULL
of	NULL
Ad	NULL
and	NULL
HPV	NULL
.	NULL

7646	NULL
ROUTES	NULL
AND	NULL
RYAN	NULL
ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Genentech	NULL
for	NULL
supplying	NULL
the	NULL
recombinant	NULL
IFN-y	NULL
;	NULL
E.	NULL
Harlow	NULL
for	NULL
monoclonal	NULL
antibody	NULL
M73	NULL
;	NULL
M.	NULL
Gama	NULL
Sosa	NULL
and	NULL
R.	NULL
Reprecht	NULL
for	NULL
HeLa	NULL
c-env	NULL
;	NULL
C.	NULL
Miinger	NULL
for	NULL
HFK-1321	NULL
and	NULL
18NCO	NULL
;	NULL
D.	NULL
Galloway	NULL
for	NULL
pLSXN16E7/16E6	NULL
and	NULL
pLSXN16E7	NULL
;	NULL
A.	NULL
Berk	NULL
for	NULL
IC4	NULL
;	NULL
S.	NULL
Frisch	NULL
for	NULL
H4	NULL
,	NULL
P2AHT2A	NULL
,	NULL
and	NULL
M18	NULL
;	NULL
A.	NULL
Deisseroth	NULL
for	NULL
the	NULL
IRF-1	NULL
cDNA	NULL
probe	NULL
,	NULL
J.	NULL
Domenico	NULL
and	NULL
E.	NULL
Gelfand	NULL
for	NULL
the	NULL
GADPH	NULL
cDNA	NULL
probe	NULL
;	NULL
J.	NULL
Cook	NULL
,	NULL
D.	NULL
Klemm	NULL
,	NULL
M.	NULL
Chen	NULL
,	NULL
and	NULL
S.	NULL
Benedict	NULL
for	NULL
critical	NULL
reviews	NULL
of	NULL
the	NULL
manu-script	NULL
;	NULL
and	NULL
B.	NULL
Silverstein	NULL
,	NULL
N.	NULL
DeStackelberg	NULL
,	NULL
and	NULL
L.	NULL
Landskroner	NULL
for	NULL
assistance	NULL
with	NULL
illustrations	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grant	NULL
AI-32136	NULL
(	NULL
J.M.R	NULL
.	NULL
)	NULL

from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Anderson	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Fennie	NULL
.	NULL

1987	NULL
.	NULL

Adenovirus	NULL
carly	NULL
region	NULL
1A	NULL
modulation	NULL
of	NULL
interferon	NULL
antiviral	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:787-795	NULL
.	NULL

2	NULL
.	NULL

Baker	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
W.	NULL
C.	NULL
Phelps	NULL
,	NULL
M.	NULL
J.	NULL
Lindgren	NULL
,	NULL
M.	NULL
A.	NULL
Gonda	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Howley	NULL
.	NULL

1987	NULL
.	NULL

Structural	NULL
and	NULL
translational	NULL
analysis	NULL
of	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
sequences	NULL
in	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:962-971	NULL
.	NULL

3	NULL
.	NULL

Bergsagel	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Finegold	NULL
,	NULL
J.	NULL
Butel	NULL
,	NULL
W.	NULL
Kupsky	NULL
,	NULL
and	NULL
R.	NULL
Garcea	NULL
.	NULL

1992	NULL
.	NULL

DNA	NULL
sequences	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
in	NULL
ependyomas	NULL
and	NULL
choroid	NULL
plexus	NULL
tumors	NULL
of	NULL
childhood	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

326:988-993	NULL
.	NULL

4	NULL
.	NULL

Brunet	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1988	NULL
.	NULL

Concentration	NULL
dependence	NULL
of	NULL
transcriptional	NULL
transactivation	NULL
in	NULL
inducible	NULL
E1A-containing	NULL
human	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:4799-4807	NULL
.	NULL

5	NULL
.	NULL

Bukowski	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Welsh	NULL
.	NULL

1985	NULL
.	NULL

Inability	NULL
of	NULL
interferon	NULL
to	NULL
protect	NULL
virus-infected	NULL
cells	NULL
against	NULL
lysis	NULL
by	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
correlates	NULL
with	NULL
NK	NULL
cell-mediated	NULL
antiviral	NULL
effects	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

135:3537-3541	NULL
.	NULL

6	NULL
.	NULL

Burgert	NULL
,	NULL
H.	NULL
G.	NULL
,	NULL
J.	NULL
L.	NULL
Maryanski	NULL
,	NULL
and	NULL
S.	NULL
Kvist	NULL
.	NULL

1987	NULL
.	NULL

``	NULL
E3/19K	NULL
``	NULL
protein	NULL
of	NULL
adenovirus	NULL
type	NULL
2	NULL
inhibits	NULL
lysis	NULL
of	NULL
cytolytic	NULL
T	NULL
lymphocytes	NULL
by	NULL
blocking	NULL
cell-surface	NULL
expression	NULL
of	NULL
histocompatibility	NULL
class	NULL
I	NULL
antigen	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:1356-1360	NULL
.	NULL

7	NULL
.	NULL

Butel	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
S.	NULL
S.	NULL
Tevethia	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Melnick	NULL
.	NULL

1972	NULL
.	NULL

Oncogenicity	NULL
and	NULL
cell	NULL
transformation	NULL
by	NULL
papovavirus	NULL
SV40	NULL
:	NULL
the	NULL
role	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

15:1-55	NULL
.	NULL

8	NULL
.	NULL

Carbone	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
I	NULL
.	NULL

Pass	NULL
,	NULL
P.	NULL
Rizzo	NULL
,	NULL
M.	NULL
R.	NULL
Marininetti	NULL
,	NULL
M.	NULL
Di	NULL
Muzio	NULL
,	NULL
D.	NULL
J.	NULL
Y.	NULL
Mew	NULL
,	NULL
A.	NULL
S.	NULL
Levine	NULL
,	NULL
and	NULL
A.	NULL
Procopio	NULL
.	NULL

1994	NULL
.	NULL

Simian	NULL
virus	NULL
40-like	NULL
DNA	NULL
sequences	NULL
in	NULL
human	NULL
pleural	NULL
mesothelioma	NULL
.	NULL

Oncogene	NULL
9:1781-1790	NULL
.	NULL

9	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
J.	NULL
Hibbs	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
J.	NULL
Lewis	NULL
.	NULL

1980	NULL
.	NULL

Resistance	NULL
of	NULL
simian	NULL
virus	NULL
40-transformed	NULL
hamster	NULL
cells	NULL
to	NULL
the	NULL
cytolytic	NULL
effect	NULL
of	NULL
activated	NULL
mac-rophages	NULL
:	NULL
a	NULL
possible	NULL
factor	NULL
in	NULL
species	NULL
specific	NULL
viral	NULL
oncogenicity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:6773-6777	NULL
.	NULL

10	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
J.	NULL
R.	NULL
Hibbs	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Lewis	NULL
,	NULL
Jr.	NULL
1982	NULL
.	NULL

DNA	NULL
virus-transformed	NULL
hamster	NULL
cell-host	NULL
effector	NULL
cell	NULL
interactions	NULL
:	NULL
level	NULL
of	NULL
resistance	NULL
to	NULL
cytolysis	NULL
correlated	NULL
with	NULL
tumorigenicity	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
30:795-803	NULL
.	NULL

11	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Lewis	NULL
,	NULL
Jr.	NULL
1984	NULL
.	NULL

Differential	NULL
NK	NULL
cell	NULL
and	NULL
macrophage	NULL
killing	NULL
of	NULL
hamster	NULL
cells	NULL
infected	NULL
with	NULL
nononcogenic	NULL
or	NULL
oncogenic	NULL
adenovirus	NULL
.	NULL

Science	NULL
224:612-615	NULL
.	NULL

12	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Lewis	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Immunological	NULL
surveillance	NULL
against	NULL
DNA	NULL
virus-transformed	NULL
cells	NULL
:	NULL
correlations	NULL
between	NULL
natural	NULL
killer	NULL
cell	NULL
cytolytic	NULL
competence	NULL
and	NULL
tumor	NULL
susceptibility	NULL
of	NULL
athymic	NULL
rodents	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61	NULL
:	NULL
2155-2161	NULL
.	NULL

13	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
D.	NULL
L.	NULL
May	NULL
,	NULL
A.	NULL
Lewis	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Walker	NULL
.	NULL

1987	NULL
.	NULL

Adenovirus	NULL
E1A	NULL
gene	NULL
induction	NULL
of	NULL
susceptibility	NULL
to	NULL
lysis	NULL
by	NULL
natural	NULL
killer	NULL
cells	NULL
and	NULL
activated	NULL
macrophages	NULL
in	NULL
infected	NULL
rodent	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3510-3520	NULL
.	NULL

14	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
T.	NULL
A.	NULL
Walker	NULL
,	NULL
A.	NULL
M.	NULL
Lewis	NULL
,	NULL
Jr.	NULL
,	NULL
H.	NULL
E.	NULL
Ruley	NULL
,	NULL
F.	NULL
L.	NULL
Graham	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Pilder	NULL
.	NULL

1986	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
adenovirus	NULL
E1A	NULL
oncogene	NULL
during	NULL
cell	NULL
transformation	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
susceptibility	NULL
to	NULL
lysis	NULL
by	NULL
host	NULL
inflammatory	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:6965-6969	NULL
.	NULL

15	NULL
.	NULL

Cook	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Wilson	NULL
,	NULL
L.	NULL
A.	NULL
Wolf	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Walker	NULL
.	NULL

1993	NULL
.	NULL

E1A	NULL
oncogene	NULL
expression	NULL
level	NULL
in	NULL
sarcoma	NULL
cells	NULL
:	NULL
an	NULL
independent	NULL
determinant	NULL
of	NULL
cytolytic	NULL
susceptibility	NULL
and	NULL
tumor	NULL
rejection	NULL
.	NULL

Oncogene	NULL
8:625-635	NULL
.	NULL

16	NULL
.	NULL

Dyson	NULL
,	NULL
N.	NULL
,	NULL
R.	NULL
Bernards	NULL
,	NULL
S.	NULL
Friend	NULL
,	NULL
L.	NULL
Gooding	NULL
,	NULL
J.	NULL
Hassell	NULL
,	NULL
E.	NULL
Major	NULL
,	NULL
J.	NULL
Pipas	NULL
,	NULL
T.	NULL
VanDyke	NULL
,	NULL
and	NULL
E.	NULL
Harlow	NULL
.	NULL

1990	NULL
.	NULL

Large	NULL
T	NULL
antigens	NULL
of	NULL
many	NULL
polyomaviruses	NULL
are	NULL
able	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64	NULL
:	NULL
1353-1356	NULL
.	NULL

17	NULL
.	NULL

Dyson	NULL
,	NULL
N.	NULL
,	NULL
K.	NULL
Buchkovich	NULL
,	NULL
P.	NULL
Whyte	NULL
,	NULL
and	NULL
E.	NULL
Harlow	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
cellular	NULL
107K	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
adenovirus	NULL
E1A	NULL
also	NULL
associates	NULL
with	NULL
the	NULL
large	NULL
T	NULL
antigens	NULL
of	NULL
SV40	NULL
and	NULL
JC	NULL
virus	NULL
.	NULL

Cell	NULL
58:249-255	NULL
.	NULL

18	NULL
.	NULL

Dyson	NULL
,	NULL
N.	NULL
,	NULL
P.	NULL
Guida	NULL
,	NULL
K.	NULL
Miinger	NULL
,	NULL
and	NULL
E.	NULL
Harlow	NULL
.	NULL

1993	NULL
.	NULL

Homologous	NULL
sequences	NULL
in	NULL
adenovirus	NULL
E1A	NULL
and	NULL
human	NULL
papillomavirus	NULL
E7	NULL
proteins	NULL
mediate	NULL
interaction	NULL
with	NULL
the	NULL
same	NULL
set	NULL
of	NULL
cellular	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6893-6902	NULL
.	NULL

19	NULL
.	NULL

Dyson	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
E.	NULL
Harlow	NULL
.	NULL

1992	NULL
.	NULL

Adenovirus	NULL
E1A	NULL
targets	NULL
key	NULL
regulators	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

Cancer	NULL
Surv	NULL
.	NULL

12:161-195	NULL
.	NULL

20	NULL
.	NULL

Egan	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Jelsma	NULL
,	NULL
J.	NULL
Howe	NULL
,	NULL
S.	NULL
Bayley	NULL
,	NULL
B.	NULL
Ferguson	NULL
,	NULL
and	NULL
P.	NULL
Branton	NULL
.	NULL

1988	NULL
.	NULL

Mapping	NULL
of	NULL
cellular	NULL
protein-binding	NULL
sites	NULL
on	NULL
the	NULL
products	NULL
of	NULL
early-region	NULL
1A	NULL
of	NULL
human	NULL
adenovirus	NULL
type	NULL
5	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:3955-3959	NULL
.	NULL

21	NULL
.	NULL

Ellis	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
McKenzie	NULL
,	NULL
P.	NULL
Simms	NULL
,	NULL
B.	NULL
Helfrich	NULL
,	NULL
and	NULL
R.	NULL
Fisher	NULL
.	NULL

1989	NULL
.	NULL

Induction	NULL
of	NULL
human	NULL
lymphokine-activated	NULL
killer	NULL
cells	NULL
by	NULL
IFN-	NULL
«	NULL
and	NULL
IFN-y	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:4282-4286	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

Fresa	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
H.	NULL
E.	NULL
Karjalainen	NULL
,	NULL
and	NULL
S.	NULL
S.	NULL
Tevethia	NULL
.	NULL

1987	NULL
.	NULL

Sensitivity	NULL
of	NULL
simian	NULL
virus	NULL
40-transformed	NULL
C57BL/6	NULL
mouse	NULL
embryo	NULL
fibroblasts	NULL
to	NULL
lysis	NULL
by	NULL
murine	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:1215-1220	NULL
.	NULL

Frisch	NULL
,	NULL
S.	NULL
M.	NULL
1991	NULL
.	NULL

Antioncogenic	NULL
effect	NULL
of	NULL
adenovirus	NULL
E1A	NULL
in	NULL
human	NULL
tumor	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:9077-9081	NULL
.	NULL

Furbert-Harris	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Evans	NULL
,	NULL
C.	NULL
Woodworth	NULL
,	NULL
and	NULL
J.	NULL
DiPaolo	NULL
.	NULL

1989	NULL
.	NULL

Loss	NULL
of	NULL
leukoregulin	NULL
up-regulation	NULL
of	NULL
natural	NULL
killer	NULL
but	NULL
not	NULL
lymphokine-activated	NULL
killer	NULL
lymphocytotoxicity	NULL
in	NULL
human	NULL
papillomavirus	NULL
16	NULL
DNA-immortalized	NULL
cervical	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

81:1080-1085.	NULL
.	NULL

Gallimore	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
and	NULL
C.	NULL
Paraskeva	NULL
.	NULL

1980	NULL
.	NULL

A	NULL
study	NULL
to	NULL
determine	NULL
the	NULL
reasons	NULL
for	NULL
differences	NULL
in	NULL
the	NULL
tumorigenicity	NULL
of	NULL
rat	NULL
cell	NULL
lines	NULL
transformed	NULL
by	NULL
adenovirus	NULL
2	NULL
and	NULL
adenovirus	NULL
12	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

44:703-713	NULL
.	NULL

Gama	NULL
Sosa	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
R.	NULL
DeGasperi	NULL
,	NULL
F.	NULL
Fazely	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Ruprecht	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
HIV	NULL
env	NULL
and	NULL
tet	NULL
gene	NULL
products	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

161:305-311	NULL
.	NULL

Gooding	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
L.	NULL
Aquino	NULL
,	NULL
P.	NULL
J.	NULL
Duerksen-Hughes	NULL
,	NULL
D.	NULL
Day	NULL
,	NULL
T.	NULL
M.	NULL
Horton	NULL
,	NULL
S.	NULL
Yei	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
M.	NULL
Wold	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
E1B	NULL
19,000-molecular-weight	NULL
protein	NULL
of	NULL
group	NULL
C	NULL
adenoviruses	NULL
prevents	NULL
tumor	NULL
necrosis	NULL
factor	NULL
cytolysis	NULL
of	NULL
human	NULL
cells	NULL
but	NULL
not	NULL
of	NULL
mouse	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3083-3094	NULL
.	NULL

Gooding	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
L.	NULL
W.	NULL
Elmore	NULL
,	NULL
A.	NULL
E.	NULL
Tollefson	NULL
,	NULL
H.	NULL
A.	NULL
Brady	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
Wold	NULL
.	NULL

1988	NULL
.	NULL

14,700	NULL
MW	NULL
protein	NULL
from	NULL
the	NULL
E3	NULL
region	NULL
of	NULL
adenovirus	NULL
inhibits	NULL
cytolysis	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Cell	NULL
53:341-346	NULL
.	NULL

Graham	NULL
,	NULL
F.	NULL
L.	NULL
1984	NULL
.	NULL

Transformation	NULL
by	NULL
and	NULL
oncogenicity	NULL
of	NULL
human	NULL
adeno-viruses	NULL
,	NULL
p.	NULL
339-398	NULL
.	NULL

In	NULL
H.	NULL
S.	NULL
Ginsberg	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
The	NULL
adenoviruses	NULL
.	NULL

Plenum	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Green	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
Wold	NULL
,	NULL
J.	NULL
Mackey	NULL
,	NULL
and	NULL
P.	NULL
Rigden	NULL
.	NULL

1979	NULL
.	NULL

Analysis	NULL
of	NULL
human	NULL
tonsil	NULL
and	NULL
cancer	NULL
DNAs	NULL
and	NULL
RNAs	NULL
for	NULL
DNA	NULL
sequences	NULL
of	NULL
group	NULL
C	NULL
(	NULL
sero-types	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5	NULL
and	NULL
6	NULL
)	NULL
human	NULL
adenovirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
76:6606-6610	NULL
.	NULL

Gutch	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
N.	NULL
Reich	NULL
.	NULL

1991	NULL
.	NULL

Repression	NULL
of	NULL
the	NULL
interferon	NULL
signal	NULL
trans-duction	NULL
pathway	NULL
by	NULL
the	NULL
adenovirus	NULL
E1A	NULL
oncogene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7913-7917	NULL
.	NULL

Halbert	NULL
,	NULL
C.	NULL
,	NULL
G.	NULL
Demers	NULL
,	NULL
and	NULL
D.	NULL
Galloway	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
E7	NULL
gene	NULL
of	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
is	NULL
sufficient	NULL
for	NULL
immortalization	NULL
of	NULL
human	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:473-478	NULL
.	NULL

Harlow	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Franza	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
C.	NULL
Schley	NULL
.	NULL

1985	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
adenovirus	NULL
early	NULL
region	NULL
1A	NULL
proteins	NULL
:	NULL
extensive	NULL
heterogeneity	NULL
in	NULL
early	NULL
region	NULL
1A	NULL
products	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

55:533-546	NULL
.	NULL

Houweling	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
J.	NULL
van	NULL
den	NULL
Elsen	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
van	NULL
der	NULL
Eb	NULL
.	NULL

1980	NULL
.	NULL

Partial	NULL
transformation	NULL
of	NULL
primary	NULL
rat	NULL
cells	NULL
by	NULL
the	NULL
leftmost	NULL
4.5	NULL
%	NULL
fragment	NULL
of	NULL
adenovirus	NULL
5	NULL
DNA	NULL
.	NULL

Virology	NULL
105:537-550	NULL
.	NULL

Howes	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
N.	NULL
Ransom	NULL
,	NULL
D.	NULL
S.	NULL
Papermaster	NULL
,	NULL
J.	NULL
G.	NULL
H.	NULL
Lasudry	NULL
,	NULL
D.	NULL
M.	NULL
Albert	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Windle	NULL
.	NULL

1994	NULL
.	NULL

Apoptosis	NULL
or	NULL
retinoblastoma	NULL
:	NULL
alternative	NULL
fates	NULL
of	NULL
photoreceptors	NULL
expressing	NULL
the	NULL
HPV-16	NULL
E7	NULL
gene	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
p53	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1300-1310	NULL
.	NULL

Kalvakolanu	NULL
,	NULL
D.	NULL
V.	NULL
R.	NULL
,	NULL
S.	NULL
K.	NULL
Bandyopadhyay	NULL
,	NULL
M.	NULL
L.	NULL
Harter	NULL
,	NULL
and	NULL
G.	NULL
C.	NULL
Sen.	NULL
1991	NULL
.	NULL

Inhibition	NULL
of	NULL
interferon-inducible	NULL
gene	NULL
expression	NULL
by	NULL
adenovirus	NULL
E1A	NULL
proteins	NULL
:	NULL
block	NULL
in	NULL
transcriptional	NULL
complex	NULL
formation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7459-7463	NULL
.	NULL

Kitajewski	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
J.	NULL
Schneider	NULL
,	NULL
B	NULL
.	NULL

Safer	NULL
,	NULL
and	NULL
T.	NULL
Shenk	NULL
.	NULL

1986	NULL
.	NULL

An	NULL
adenovirus	NULL
mutant	NULL
unable	NULL
to	NULL
express	NULL
VAI	NULL
RNA	NULL
displays	NULL
different	NULL
growth	NULL
responses	NULL
and	NULL
sensitivity	NULL
to	NULL
interferon	NULL
in	NULL
various	NULL
host	NULL
cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

64493-4498	NULL
.	NULL

Koutsky	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
D.	NULL
A.	NULL
Galloway	NULL
,	NULL
and	NULL
K.	NULL
K.	NULL
Holmes	NULL
.	NULL

1988	NULL
.	NULL

Epidemiology	NULL
of	NULL
genital	NULL
human	NULL
papillomavirus	NULL
infection	NULL
.	NULL

Epidemiol	NULL
.	NULL

Rev	NULL
.	NULL

10:122-162	NULL
.	NULL

Lewis	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cook	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
interface	NULL
between	NULL
adenovirus-transformed	NULL
cells	NULL
and	NULL
cellular	NULL
immune	NULL
response	NULL
in	NULL
the	NULL
challenged	NULL
host	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

110:1-22	NULL
.	NULL

Lewis	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
J.	NULL
L	NULL
Cook	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
new	NULL
role	NULL
for	NULL
DNA	NULL
virus	NULL
carly	NULL
proteins	NULL
in	NULL
viral	NULL
carcinogenesis	NULL
.	NULL

Science	NULL
227:15-20	NULL
.	NULL

Malejezyk	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Majewski	NULL
,	NULL
S.	NULL
Jablonska	NULL
,	NULL
T.	NULL
T.	NULL
Rogozinski	NULL
,	NULL
and	NULL
G.	NULL
Orth	NULL
.	NULL

1989	NULL
.	NULL

Abrogated	NULL
NK-cell	NULL
lysis	NULL
of	NULL
human	NULL
papillomavirus	NULL
(	NULL
HPV	NULL
)	NULL
-16-bearing	NULL
keratinocytes	NULL
in	NULL
patients	NULL
with	NULL
pre-cancerous	NULL
and	NULL
cancerous	NULL
HPV-induced	NULL
anogenital	NULL
lesions	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
43:209-214	NULL
.	NULL

Malejezyk	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Malejezyk	NULL
,	NULL
A.	NULL
Urbanski	NULL
,	NULL
A.	NULL
Kock	NULL
,	NULL
S.	NULL
Jablonska	NULL
,	NULL
G.	NULL
Orth	NULL
,	NULL
and	NULL
T.	NULL
Luger	NULL
.	NULL

1991	NULL
.	NULL

Constitutive	NULL
release	NULL
of	NULL
IL6	NULL
by	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
(	NULL
HPV-16	NULL
)	NULL
-harboring	NULL
keratinocytes	NULL
:	NULL
a	NULL
mechanism	NULL
augmenting	NULL
the	NULL
NK-cell-mediated	NULL
lysis	NULL
of	NULL
HPV-bearing	NULL
neoplastic	NULL
cells	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

136	NULL
:	NULL
155-164	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
J.	NULL
Sambrook	NULL
.	NULL

1982	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Miinger	NULL
,	NULL
K.	NULL
,	NULL
W.	NULL
Phelps	NULL
,	NULL
V.	NULL
Bubb	NULL
,	NULL
P.	NULL
Howley	NULL
,	NULL
and	NULL
R.	NULL
Schlegel	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
E6	NULL
and	NULL
E7	NULL
genes	NULL
of	NULL
the	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
together	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
transformation	NULL
of	NULL
primary	NULL
human	NULL
keratinocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4417-4421	NULL
.	NULL

Mymryck	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Shire	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Bayley	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
adenovirus	NULL
type	NULL
5	NULL
E1A	NULL
in	NULL
rat	NULL
cells	NULL
requires	NULL
a	NULL
proliferation	NULL
block	NULL
.	NULL

Oncogene	NULL
9:1187-1193	NULL
.	NULL

Nawa	NULL
,	NULL
A.	NULL
,	NULL
Y.	NULL
Nishiyama	NULL
,	NULL
N.	NULL
Yamamoto	NULL
,	NULL
K.	NULL
Maeno	NULL
,	NULL
S.	NULL
Goto	NULL
,	NULL
and	NULL
Y.	NULL
Tomoda	NULL
.	NULL

1990	NULL
.	NULL

Selective	NULL
suppression	NULL
of	NULL
human	NULL
papilloma	NULL
virus	NULL
type	NULL
18	NULL
mRNA	NULL
level	NULL
in	NULL
HeLa	NULL
cells	NULL
by	NULL
interferon	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

170:793-799	NULL
.	NULL

Vou	NULL
.	NULL

69	NULL
,	NULL
1995	NULL
47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

Nielsch	NULL
,	NULL
U.	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
S.	NULL
G.	NULL
Zimmer	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Babiss	NULL
.	NULL

1992	NULL
.	NULL

Induced	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
beta	NULL
interferon	NULL
gene	NULL
in	NULL
adenovirus	NULL
type	NULL
5-trans-formed	NULL
rat	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:1884-1890	NULL
.	NULL

Pan	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Griep	NULL
.	NULL

1994	NULL
.	NULL

Altered	NULL
cell	NULL
cycle	NULL
regulation	NULL
in	NULL
the	NULL
lens	NULL
of	NULL
HPV-16	NULL
E6	NULL
or	NULL
E7	NULL
transgenic	NULL
mice	NULL
:	NULL
implications	NULL
for	NULL
tumor	NULL
supressor	NULL
gene	NULL
function	NULL
in	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1285-1299	NULL
.	NULL

Phelps	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
C.	NULL
L.	NULL
Yee	NULL
,	NULL
K.	NULL
Miinger	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Howley	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
E7	NULL
gene	NULL
encodes	NULL
transactivation	NULL
and	NULL
transformation	NULL
functions	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
adenovirus	NULL
E1A	NULL
.	NULL

Cell	NULL
53:539-547	NULL
.	NULL

Pietenpol	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Stein	NULL
,	NULL
E.	NULL
Moran	NULL
,	NULL
P.	NULL
Yaciuk	NULL
,	NULL
R.	NULL
Schlegel	NULL
,	NULL
R.	NULL
Lyons	NULL
,	NULL
M.	NULL
Pittelkow	NULL
,	NULL
K.	NULL
Miinger	NULL
,	NULL
P.	NULL
Howley	NULL
,	NULL
and	NULL
H.	NULL
Moses	NULL
.	NULL

1990	NULL
.	NULL

TGF-B1	NULL
inhibition	NULL
of	NULL
c-myc	NULL
transcription	NULL
and	NULL
growth	NULL
in	NULL
keratinocytes	NULL
is	NULL
abrogated	NULL
by	NULL
viral	NULL
transforming	NULL
proteins	NULL
with	NULL
pRB	NULL
binding	NULL
domains	NULL
.	NULL

Cell	NULL
61:777-785	NULL
.	NULL

Pitkaranta	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Hovi	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
interferon	NULL
in	NULL
human	NULL
leuco-cyte	NULL
cultures	NULL
by	NULL
natural	NULL
pathogenic	NULL
respiratory	NULL
viruses	NULL
.	NULL

J.	NULL
Interferon	NULL
Res	NULL
.	NULL

13:423-426	NULL
.	NULL

Rao	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Debbas	NULL
,	NULL
P.	NULL
Sabbatini	NULL
,	NULL
D.	NULL
Hockenbery	NULL
,	NULL
S.	NULL
Korsmeyer	NULL
,	NULL
and	NULL
E.	NULL
White	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
adenovirus	NULL
E1A	NULL
proteins	NULL
induce	NULL
apoptosis	NULL
,	NULL
which	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
E1B	NULL
19-kDa	NULL
and	NULL
Bel-2	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7742-7746	NULL
.	NULL

Routes	NULL
,	NULL
J.	NULL
M.	NULL
1992	NULL
.	NULL

Interferon	NULL
increases	NULL
class	NULL
I	NULL
MHC	NULL
Ag	NULL
expression	NULL
on	NULL
adenovirus	NULL
infected	NULL
human	NULL
cells	NULL
without	NULL
inducing	NULL
resistance	NULL
to	NULL
NK	NULL
cell	NULL
killing	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:2372-2377	NULL
.	NULL

Routes	NULL
,	NULL
J.	NULL
M.	NULL
1993	NULL
.	NULL

Adenovirus	NULL
E1A	NULL
inhibits	NULL
IFN-induced	NULL
resistance	NULL
to	NULL
cytolysis	NULL
by	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:4315-4322	NULL
.	NULL

Routes	NULL
,	NULL
J.	NULL
M.	NULL
Unpublished	NULL
data	NULL
.	NULL

Routes	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cook	NULL
.	NULL

1989	NULL
.	NULL

Adenovirus	NULL
persistence	NULL
in	NULL
man	NULL
:	NULL
defective	NULL
E1A	NULL
gene	NULL
product	NULL
targeting	NULL
of	NULL
infected	NULL
cells	NULL
for	NULL
killing	NULL
by	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:4022-4026	NULL
.	NULL

Routes	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cook	NULL
.	NULL

1995	NULL
.	NULL

E1A	NULL
gene	NULL
expression	NULL
induces	NULL
susceptibility	NULL
to	NULL
killing	NULL
by	NULL
NK	NULL
cells	NULL
following	NULL
immortalization	NULL
but	NULL
not	NULL
adenovirus-infection	NULL
of	NULL
human	NULL
cells	NULL
.	NULL

Virology	NULL
210:421-428	NULL
.	NULL

Routes	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Metz	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cook	NULL
.	NULL

1993	NULL
.	NULL

Endogenous	NULL
expression	NULL
of	NULL
E1A	NULL
in	NULL
human	NULL
cells	NULL
enhances	NULL
the	NULL
effect	NULL
of	NULL
adenovirus	NULL
E3	NULL
on	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
antigen	NULL
expression	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:3176-3181	NULL
.	NULL

Sawada	NULL
,	NULL
Y.	NULL
,	NULL
B.	NULL
Fohring	NULL
,	NULL
T.	NULL
E.	NULL
Shenk	NULL
,	NULL
and	NULL
K.	NULL
Raska	NULL
,	NULL
Jr.	NULL
1985	NULL
.	NULL

Tumorigenicity	NULL
of	NULL
adenovirus-transformed	NULL
cells	NULL
;	NULL
region	NULL
E1A	NULL
of	NULL
adenovirus	NULL
12	NULL
confers	NULL
resistance	NULL
to	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Virology	NULL
147:413-421	NULL
.	NULL

Scheffner	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Werness	NULL
,	NULL
J.	NULL
Huibregtse	NULL
,	NULL
A.	NULL
Levine	NULL
,	NULL
and	NULL
P.	NULL
Howley	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
E6	NULL
oncoprotein	NULL
encoded	NULL
by	NULL
human	NULL
papillomavirus	NULL
types	NULL
16	NULL
and	NULL
18	NULL
promotes	NULL
the	NULL
degradation	NULL
of	NULL
p53	NULL
.	NULL

Cell	NULL
63:1129-1136	NULL
.	NULL

Schwarz	NULL
,	NULL
E.	NULL
,	NULL
U.	NULL
K.	NULL
Freese	NULL
,	NULL
L.	NULL
Gissmann	NULL
,	NULL
W.	NULL
Mayer	NULL
,	NULL
B.	NULL
Roggenbuck	NULL
,	NULL
A.	NULL
Sremlau	NULL
,	NULL
and	NULL
H.	NULL
zur	NULL
Hausen	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
papillomavirus	NULL
sequences	NULL
in	NULL
cervical	NULL
carcinoma	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
314	NULL
:	NULL
111-114	NULL
.	NULL

Sheil	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
P.	NULL
H.	NULL
Gallimore	NULL
,	NULL
S.	NULL
G.	NULL
Zimmer	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Sopori	NULL
.	NULL

1984	NULL
.	NULL

NK	NULL
LYSIS	NULL
OF	NULL
HPV-	NULL
AND	NULL
Ad-TRANSFORMED	NULL
CELLS	NULL
63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

7647	NULL
Susceptibility	NULL
of	NULL
adenovirus	NULL
2-transformed	NULL
rat	NULL
cell	NULL
lines	NULL
to	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
:	NULL
direct	NULL
correlation	NULL
between	NULL
NK	NULL
resistance	NULL
and	NULL
in	NULL
vivo	NULL
tumorigen-esis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

132:1578-1582	NULL
.	NULL

Sims	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
C.	NULL
Ying	NULL
,	NULL
M.	NULL
F.	NULL
Romine	NULL
,	NULL
P.-Q	NULL
.	NULL

Gao	NULL
,	NULL
K.	NULL
Gottlieb	NULL
,	NULL
and	NULL
A.	NULL
Deis-seroth	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
novel	NULL
interferon-inducible	NULL
domain	NULL
:	NULL
structural	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
gene	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:690-702	NULL
.	NULL

Smotkin	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
F.	NULL
O.	NULL
Wettstein	NULL
.	NULL

1986	NULL
.	NULL

Transcription	NULL
of	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
early	NULL
genes	NULL
in	NULL
cervical	NULL
cancer	NULL
and	NULL
a	NULL
cervical	NULL
cancer	NULL
derived	NULL
cell	NULL
line	NULL
and	NULL
identification	NULL
of	NULL
the	NULL
E7	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
:	NULL
4680-4684	NULL
.	NULL

Straus	NULL
,	NULL
S.	NULL
E.	NULL
1984	NULL
.	NULL

Adenovirus	NULL
infections	NULL
in	NULL
humans	NULL
.	NULL

Plenum	NULL
Press	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Tay	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Jenkins	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Singer	NULL
,	NULL
1987	NULL
.	NULL

Natural	NULL
killer	NULL
cells	NULL
in	NULL
cervical	NULL
intraepithelial	NULL
neoplasia	NULL
and	NULL
human	NULL
papillomavirus	NULL
infection	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Obstet	NULL
.	NULL

Gynecol	NULL
.	NULL

94:901-906	NULL
.	NULL

Thomas	NULL
,	NULL
P.	NULL
1978	NULL
.	NULL

Hybridization	NULL
of	NULL
denatured	NULL
RNA	NULL
and	NULL
small	NULL
DNA	NULL
fragments	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:5201	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Matsumoto-Kobayashi	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
J.	NULL
Seehra	NULL
,	NULL
L.	NULL
London	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1984	NULL
.	NULL

Response	NULL
of	NULL
resting	NULL
human	NULL
peripheral	NULL
blood	NULL
natural	NULL
killer	NULL
cells	NULL
to	NULL
interleukin	NULL
2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

160:1147-1169	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
Santoli	NULL
,	NULL
and	NULL
B.	NULL
Knowles	NULL
.	NULL

1977	NULL
.	NULL

Tumour	NULL
cell	NULL
lines	NULL
induce	NULL
interferon	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
270:611-613	NULL
.	NULL

Vousden	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Jat	NULL
.	NULL

1989	NULL
.	NULL

Functional	NULL
similarity	NULL
between	NULL
HPV16	NULL
E7	NULL
,	NULL
SV40	NULL
large	NULL
T	NULL
and	NULL
adenovirus	NULL
Ela	NULL
proteins	NULL
.	NULL

Oncogene	NULL
4:153-158	NULL
.	NULL

Vousden	NULL
,	NULL
K.	NULL
1993	NULL
.	NULL

Interactions	NULL
of	NULL
human	NULL
papillomavirus	NULL
transforming	NULL
proteins	NULL
with	NULL
the	NULL
products	NULL
of	NULL
the	NULL
tumor	NULL
suppressor	NULL
genes	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

7:872-879	NULL
.	NULL

Walker	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Wilson	NULL
,	NULL
A.	NULL
M.	NULL
Lewis	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Cook	NULL
.	NULL

1991	NULL
.	NULL

ElA	NULL
oncogene	NULL
induction	NULL
of	NULL
cytolytic	NULL
susceptibility	NULL
eliminates	NULL
sarcoma	NULL
cell	NULL
tumorigenicity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:6491-6495	NULL
.	NULL

Woodworth	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
U.	NULL
Lichti	NULL
,	NULL
S.	NULL
Simpson	NULL
,	NULL
C.	NULL
H.	NULL
Evans	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
DiPaolo	NULL
.	NULL

1992	NULL
.	NULL

Leukoregulin	NULL
and	NULL
y-interferon	NULL
inhibit	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
gene	NULL
transcription	NULL
in	NULL
human	NULL
papillomavirus-immortalized	NULL
human	NULL
cervical	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

52:456-463	NULL
.	NULL

Yee	NULL
,	NULL
C.	NULL
,	NULL
I	NULL
Krishnan-Hewlett	NULL
,	NULL
C.	NULL
Baker	NULL
,	NULL
R.	NULL
Schlegel	NULL
,	NULL
and	NULL
P.	NULL
Howley	NULL
.	NULL

1985	NULL
.	NULL

Presence	NULL
and	NULL
expression	NULL
of	NULL
human	NULL
papillomavirus	NULL
sequences	NULL
in	NULL
human	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
lines	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

119:361-366	NULL
.	NULL

Yew	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1992	NULL
.	NULL

Inhibition	NULL
of	NULL
p53	NULL
transactivation	NULL
required	NULL
for	NULL
transformation	NULL
by	NULL
adenovirus	NULL
early	NULL
1B	NULL
protein	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
357	NULL
:	NULL
82-85	NULL
.	NULL

Zantema	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
I.	NULL
Schrier	NULL
,	NULL
A.	NULL
Davis-Olivier	NULL
,	NULL
T.	NULL
van	NULL
Laar	NULL
,	NULL
R.	NULL
T.	NULL
M.	NULL
J.	NULL
Vaessen	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
van	NULL
der	NULL
Eb	NULL
.	NULL

1985	NULL
.	NULL

Adenovirus	NULL
serotype	NULL
determines	NULL
association	NULL
and	NULL
localization	NULL
of	NULL
the	NULL
large	NULL
E1B	NULL
tumor	NULL
antigen	NULL
with	NULL
cellular	NULL
tumor	NULL
antigen	NULL
p53	NULL
in	NULL
transformed	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5:3084-3091.	NULL
zur	NULL
Hausen	NULL
,	NULL
H.	NULL
1991	NULL
.	NULL

Viruses	NULL
in	NULL
human	NULL
cancers	NULL
.	NULL

Science	NULL
254:1167-1173	NULL
.	NULL

